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Résumé: 
La neuroimmunologie est la science qui étudie les interactions entre le système nerveux 
central et le système immunitaire. Différentes études morphologiques ont démontré que le 
système nerveux sympathique innerve tous les organes lymphoïdes primaires et secondaires et 
que la plus grande partie des cellules immunitaires expriment à leur surface les récepteurs 
adrénergiques nécessaires à la transduction du signal de ce système. 
Dans ce travail, nous avons montré in vivo que le blocage des récepteurs β−adrénergiques 
influence la réponse immunitaire innée de la peau au peptidoglycanne (PGN), mais pas au 
lipopolysaccharide (LPS), en induisant l’expression génique des cytokines IL-23, IL-12 et 
IFN-γ. Le blocage de ces récepteurs influence aussi la réponse immunitaire adaptative qui est 
polarisée vers une réponse de type Th1. Celle-ci a été évaluée par la mesure de la réponse 
d’hypersensibilité retardée(DTH) et par la production de cytokines dans le ganglion drainant. 
Cette réponse est aussi caractérisée par une augmentation de la migration de cellules 
dendritiques plasmacytoides au ganglion drainant le site d’injection. La migration de ces 
cellules est aussi augmentée par l’utilisation de PGN en combinaison avec de l’extrait de 
glandes salivaires (EGS) des tiques Ixodes ricinus. Cette observation suggère que l’EGS 
contient des agonistes aux PRRs (pour Pattern Recognition Receptors) ou des chémokines qui 
pourraient agire en synérgie avec le PGN. Nous avons aussi démontré que le blocage 
simultané des récepteurs β1 et β2 adrénergiques est nécessaire pour influencer la réponse 
immunitaire in vivo. 
L’influence de l’activation des récepteurs β−adrénergiques par la norépinephrine (NE) sur 
la production des cytokines induites a aussi été analysée in vitro par l’activation de différents 
PRRs chez les cellules dendritiques (CDs). Nos résultats ont montré que, en accord avec les 
résultats obtenus in vivo, la NE possède des propriétés anti-inflammatoires et inhibe la 
production des cytokines IL-12, IL-23 et IL-6 chez les CDs incubées avec le PGN. La 
production de la cytokine anti-inflammatoire IL-10 est quant-à-elle induite. En outre, 
l’utilisation d’autres agonistes spécifiques pour les récepteurs TLR-2 et NOD2 ont montré 
que l’augmentation de la production d’IL-10 induite par la NE chez les CDs incubée avec du 
PGN est due à la modulation de la signalisation du récepteur TLR-2 mais pas à celle de 
Michela Manni Institut de Biologie Université de Neuchâtel 
 3 
NOD2. Cette production augmentée d’IL-10 a aussi un effet inhibiteur sur la production des 
cytokines caractéristiques des Th17, à savoir IL-6 et IL-23. 
Nous avons aussi démontré que la NE peut induire in vitro via les récepteurs β2-
adrénergiques la production d’IL-6 chez le CDs dont le récepteur NOD2 est activé. Ce 
résultat est important pour la compréhension des mécanismes régulant la production de cette 
cytokine et de la pathogenèse de maladies où une augmentation de la concentration d’IL-6 
est observée. Des résultats préliminaires ont aussi montré que l’injection chez les souris de 
CDs préalablement incubées avec les agonistes spécifiques des récepteurs β2-adrénergiques, 
TLR-2 et NOD2 en présence d’une protéine soluble, favorise le développement d’une 
réponse de type Th17 au détriment de celle de type Th1. Ceci a été évalué par l’analyse de la 
production des cytokines IL-17 et IFN-γ. Ces résultats aident à la compréhension du 
développement de la réponse Th17 et des maladies auto-immunitaires et des cancers qui en 
dépendent. 
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ABBREVIATIONS 
 
2-ME    2-mercaptoethanol 
ACh    Acetylcholine 
ACTH    Adrenocorticotropic hormone 
ANS    Autonomic nervous system 
APCs    Antigen presenting cells 
ARs    Adrenergic receptors 
BM    Bone marrow 
CAs    Catecholamines 
CARD    Caspase recruitment domain 
CLA    Cutaneous lymphocytes antigen 
CNS    Central nervous system 
CRH    Corticotropin releasing hormone 
CTLs    Cytotoxic T lymphocytes 
iE-DAP   γ-D-glutamyl-meso-diaminopimelic acid 
DCs    Dendritic cells 
DTH    Delayed type hypersensitivity response 
E    Epinephrine 
FITC    Fluorescein isothiocyanate 
GM-CSF   Granulocyte-macrophage colony-stimulating factor 
GRs    Glucocorticoid receptors 
HPA    Hypothalamic pituitary adrenal axis 
i.d.    intradermally 
IFN    Interferon 
IL    Interleukin 
KLH    Keyhole limpet hemocyanin 
LCs    Langerhans cells 
LN    Lymph node 
LPS    Lipopolysaccharide 
LRRs    Leucin rich repeats domain 
MACS    Magnetic activated cell separation 
MDP    Muramyl dipeptide 
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MHC    Major histocompatibility complex 
NE    Norepinephrine 
NKs    Natural killer cells 
NKTs    Natural killer T lymphocytes 
NOD    Nucleotide binding oligomerization domain 
PAM    N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]cyteine 
PAMPs   Pathogen associated molecular pattern 
PANS    Parasympathetic nervous system 
PBS    Phosphate buffered saline 
PCR    Polymerase-chain reaction 
pDCs    Plasmacytoid dendritic cells 
PE    Phycoerythrine 
PGN    Peptidoglycan 
PRO    Propranolol 
PRRs    Pattern recognition receptor 
SALT    Skin-associated lymphoid tissue 
SNS    Sympathetic nervous system 
STATs   Signal transducers and activators of transcription 
TCR    T cell receptor 
TGF    Transforming growth factor 
Th 1/2/17   T-helper cell type 1/2/17 
TLRs    Toll like receptors 
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1. The immune system 
 
1.1 Introduction to the immune response 
 
The immune system is not a well defined organ, as the kidney or the liver, but is composed of 
many different cell types, tissues and soluble products disseminated all around the body and 
which are engaged in the continuous fight against external attacks by infectious agents, but 
also against injuries and host generated threats, such as cancer. It is divided in two different 
parts: the innate and the adaptive, or acquired, immune system. 
The innate immune system is the ancestral system present in all multicellular organisms and it 
is the first host defense that is activated immediately after exposure to an external pathogen. 
As long as the pathogen is stopped by the innate response, the adaptive response will not be 
elicited. The innate immune system uses physical and chemical barriers to exclude antigens 
and a small number of pre-existing non specific receptors, called pattern recognition receptor 
(PRRs), to recognize conserved molecular motifs present on a broad range of pathogens 
(pathogen associated molecular pattern; PAMPs). These receptors induce a rapid, but not 
specific response to practically all infectious agents. However, no immune memory is 
generated, meaning that a second exposure to a specific antigen causes an identical response 
in magnitude and type than the first. In conclusion, the aim of the innate immune system is 
not to discriminate between pathogens but to provide an early warning system able to rapidly 
limit the infection and initiate and direct the specific adaptive immune response1. 
The adaptive immune response appeared in vertebrates 450 millions years ago and is 
complementary to the innate immune system, but differs from it in some important aspects. 
First of all, in contrast with the innate response, the adaptive response is highly specific to 
each pathogen. In fact, it is potentially able to recognize an infinite number of antigens using 
specific receptors expressed on B and T lymphocytes, the main effectors cells of the acquired 
immune system. This recognition leads to the activation of specific mechanisms for the 
production of the effector response. Compared to the innate response, the adaptive response is 
delayed but necessary for the elimination of a particular antigen. The adaptive immune 
response is also characterized by the ability to develop a memory concerning a specific 
antigen. This ability enables the organism to mount a stronger and faster response during a 
second exposure to a pathogen and allow its elimination preventing the development of 
diseases. 
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The innate and the adaptive immune response do not operate separately but by a tight 
crosstalk. For instance, elements of the innate immunity are able to enhance and direct the 
adaptive response, while cells of the acquired immune system resident nearby the surface 
barriers improve the effectiveness of the innate reaction. 
The immune response is divided in three phases, which take place at different times (Fig.1).  
 
 
 
 
 
 
 
 
Figure 1: The three phases of the immune response to an initial infection. 
 
Following the attack by a pathogen the first line of defense are the non-specific, non-inducible 
elements of the innate immune system, such as the enzymes present in the mucosa or the 
acidity of the skin. The second phase takes place 4-96 hours following the attack and involves 
the recognition of the pathogen by the PRRs. This recognition permits the induction of the 
innate host immune mechanisms, such as phagocytosis of the antigen by leukocytes or 
production of cytokines. If the antigen is completely removed by these mechanisms, the 
adaptive immune response is not activated. In contrast, if the innate immune response does 
not completely clear the pathogen, the acquired response is fully activated. 
In the following chapters the cellular and humoral mechanisms of the innate and adaptive 
immune response will be discussed. 
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1.2 The skin-associated lymphoid tissue (SALT) 
 
The skin is the largest and most exposed interface of the body in direct contact with the 
environment and consequently with an enormous quantity of pathogens potentially able to 
colonize our body and threaten our health. To cope with this danger, a complex defense 
system including physical barriers, chemical factors and cells of the innate and adaptive 
immune system developed in the skin. The immune system elements implicated in this 
defense are collectively called skin-associated lymphoid tissue (SALT). 
The skin is divided in three distinct compartments: the epidermis, the derma and the 
hypoderma (Fig. 2). 
 
a) The epidermis 
The epidermis is composed by an outer matrix of keratin fibers, which provide a physical 
barrier against external pathogen, and an inner stratified layer of keratinocytes, specialized 
squamous epithelial cells producing the keratin. In the deepest layer of the epidermis new, 
less differentiated keratinocytes are constantly produced in organized waves of cells 
physically connected by specialized intracellular tight junctions called desmosomes. The role 
of the desmosomes is to ensure the formation of horizontal layers of keratinocytes that 
migrate trough the epidermis as a unit to reach the outer keratin matrix where they die. This 
mechanism ensures the regular renewal of the skin and prevents the penetration of pathogens 
in the organism. In addition to these physical and mechanical barriers, billions of commensal 
bacteria normally colonize the skin and actively contribute to its defense by competing for 
space and nutriments with others pathogens and by secreting antimicrobial peptides. 
Moreover, Gram-positive bacteria of the normal flora secrete lipases that digest the lipids 
present on the cutaneous surface in fatty acids. These acids, together with the sebum produced 
by the sebaceous glands, contribute to the maintenance of the pH of the skin at a low level, 
which discourages the microbial replication and helps in maintaining the microbial population 
on the skin at a manageable level1. 
Till some years ago, keratinocytes were thought to be involved in the skin immune 
surveillance only as a physical barrier by maintaining the structure of the epidermis and by 
secreting keratin. However, it is now clear that keratinocytes are involved actively in the 
epidermal immune response. Several studies have in fact demonstrated the ability of the 
keratinocytes in producing important molecules necessary for the innate and adaptive immune 
Michela Manni Institut de Biologie Université de Neuchâtel 
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response2. For instance, it has been demonstrated that human and murine keratinocytes 
express constitutively some members of the Toll-like receptor (TLRs) family3,4. This 
important receptor family is a PRR implicated in the recognition of the microbes by binding 
the PAMPs derived from the pathogen and by this way triggering the innate immune response 
by the production of proinflammatory cytokines, chemokines and antimicrobial peptides. The 
keratinocytes derived cytokines, such as TNF-α, and chemokines, such as IL-8/CXCL-8, play 
an important role in the initiation of the inflammatory response and in the recruitment of 
various immune cells at the site of infection. Keratinocytes derived antimicrobial peptides, 
such as defensins and cathelicidines, are able to kill or inactivate a wide spectrum of 
microorganisms mainly by forming pores and permeabilizing the microbe membrane. 
Although keratinocytes are the major cell type of the epidermis, making up about 90% of 
epidermal cells, some T lymphocytes and epidermal dendritic cells, called Langerhans cells 
(LCs), are also found at the level of the basement membrane. In humans the majority of T 
cells found in the epidermis are αβ T cells, while in mice the γδ T cells are predominant. LCs 
present in the epidermis express CD1 as well as high levels of major histocompatibility 
complex class I and II (MHC class I and II), allowing them to effectively present peptide and 
glycolipide antigens to the T cells and triggering by this way the adaptive immune response. 
Finally, many nerve terminations are also present in the epidermis and there is growing 
evidence of a crosstalk between the nervous and the immune system in the skin5. The latest 
development of this interesting growing research will be discussed more extensively in the 
following chapters. 
 
b) The basement membrane 
The basement membrane is an additional protective layer that separates the derma from the 
epidermis. It is composed of collagen, laminin, heparan sulphate and glycosaminoglycan 
produced by keratinocytes and of fibronectin produced by dermal fibroblasts. The epidermis 
lacks blood vessels, thus the leukocytes and the important nutrients necessary for the 
maintenance of keratinocytes must exit in the dermal compartment and diffuse through the 
basement membrane. Leukocytes possess specific enzymes able to dissolve partially the 
basement membrane and allowing them to rapidly migrate from the derma to their final 
destination in the epidermis1. 
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Figure 2: The SALT structure. The skin is composed of three compartments: the epidermis, two dermal layers 
and the hypoderma. In each compartment important immune cells are found and implicated in the innate and 
adaptive immune response of the skin. LC: Langerhans cells; T: T lymphocytes; Fibro: fibroblasts; Ne: neurons; 
Mac: Macrophages; Mast: Mast cells; IDC: immature dendritic cells. (Mak, T.W., Saunders, M.E., The Immune 
Response, Basic and Clinical Principles, Academic Press, 2006.) 
 
c) The derma 
The derma is composed of two layers: the papillary derma, placed just under the basement 
membrane, and the reticular derma. Both layers are composed of collagen, which provides 
structural support to the skin, elastin fibers, which give elasticity, and hyaluronic acid, which 
is in charge of trapping the water and moisturize the skin. In the reticular derma the 
connective tissue is denser than in the papillary derma. Dermal fibroblasts are mostly 
responsible for the production of collagen and elastin but they are also implicated in the 
innate immune response by secreting important chemokines, cytokines and growth factors, 
necessary respectively for leukocytes migration, differentiation and survival6. In addition to 
fibroblasts, the derma is also composed by macrophages, dermal dendritic cells, mast cells, T 
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lymphocytes but not B lymphocytes. The leukocytes reach the derma, and later the epidermis, 
via the extravasation process in the dermal post-capillary venules. At this site the endothelial 
cells express important adhesion molecules, such as selectin, which may interact with the 
cellular adhesion molecules expressed on leukocytes and allows the binding of the immune 
cells to the endothelial wall and their passage into the tissues. The cellular adhesion molecules 
expressed both on endothelial cells and leukocytes are upregulated during the inflammatory 
process, increasing by this way the number of leukocytes entering the tissue. This permits to 
improve the effectiveness of the immune response in the skin and is an important mechanism 
regulating the passage of immune cells from the blood to the tissues. 
Dermal dendritic cells express, as LCs, high level of CD1 as well as MHC class I and II 
molecules. Even if their morphology is different, the role of these cells is similar both in the 
epidermis and in the derma. They are professional antigen presenting cells (APCs) able to 
capture, process and present antigens to T lymphocytes and activate them. 
Mast cells are also important cells implicated in the immune response in the skin. They 
express important PRRs and are able to produce cytokines and chemokines. In particular, 
mast cells possess presynthetized tumor necrosis factor (TNF), a potent inflammatory 
mediator, which can be released immediately after the exposure to a pathogen7. Moreover, 
mast cells possess granules containing histamine that can be released after specific 
stimulation and are known to be implicated in IgE hypersensitivity. 
Finally, dermal T lymphocytes represent 98% of all T cells in the skin. They are primarily 
memory T cells expressing the memory marker CD45RO and high levels of CD25. There is 
no difference in the amount of CD8+ and CD4+ T cells in the derma1. 
 
1.3 The immune response in the skin 
 
As previously explained, the immune response in the skin is the result of the interaction of 
many different mechanisms and cell types which cooperate in the defense of the skin to 
prevent infections (Fig. 3). 
When a pathogen succeeds in penetrating the skin by passing the protective keratin layer, it 
injures the underlining keratinocytes which are consequently stimulated in producing potent 
inflammatory mediators, notably IL-1α and TNF-α. These cytokines may act in a paracrine 
manner on the surrounding keratinocytes inducing them to synthesize and release additional 
inflammatory cytokines (IL-6, TNF) chemokines (IL-8) and growth factors (GM-CSF). These 
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molecules not only stimulate cells within the epidermis but are also able to diffuse through the 
basement membrane forming a chemokines gradient from the epidermis to the derma and the 
post capillaries blood vessels1. 
 
 
 
Figure 3: The immune response in the skin. . LC: Langerhans cells; T: T lymphocytes; B: B lymphocytes; 
Fibro: fibroblasts; Ne: neurons; Mac: Macrophages; Mast: Mast cells; IDC: immature dendritic cells; MDC: 
mature dendritic cells; Neu: Neutrophiles; CTL: Cytotoxic T lymphocytes; CLA: Cutaneous lymphocyte 
antigen. (Mak, T.W., Saunders, M.E., The Immune Response, Basic and Clinical Principles, Academic Press, 
2006.) 
 h 
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There, cytokines and chemokines may promote vasodilation and upregulation of the adhesion 
molecules on endothelial cells, improving consequently the extravasation of immune cells 
into the inflamed skin. Once in the tissue, leukocytes may follow the chemokines gradient and 
move from the derma into the epidermis. During this process, the essential adhesion 
molecules necessary for migration, such as the lymphocyte function-associated antigen 1 
(LFA-1), are upregulated and interact with the dermal matrix and the intercellular adhesion 
molecules (ICAM-1) expressed by fibroblasts. 
Once leukocytes reach the basement membrane, they are also induced to produce specialized 
enzymes, in particular hydrolases, able to partial digest the basement membrane and allowing 
them to migrate into the epidermis and to the site of infection, where they are fully activated 
by the presence of proinflammatory cytokines produced by injured keratinocytes. The 
complement system is also activated during the inflammatory response. Complement 
components are synthetized by keratinocytes or they can derive from the serum complement 
proteins. These complement elements may help the pathogen clearance by complement 
mediated opsonozation and phagocytosis. Mast cells are also activated by the complement 
system, which induce their degranulation and the release in the tissue of molecules 
responsible of sustaining the local inflammation. 
While the inflammatory response takes place, antigens resulting from the pathogen may be 
recognized by the PRRs of macrophages, which begin the phagocytosis process in order to 
fight against the infection. Moreover, activated macrophages are also a relevant source of 
IFN-γ that is an important Th1-cell promoter. LCs also capture and recognize antigens nearby 
the site of infection by their PRRs and, in presence of the correct cytokine microenvironment, 
they become fully mature and directly present the antigen to the epidermal memory αβ T 
cells. In contrast, epidermal γδ T cells can recognize the antigens using their TCRs and 
differentiate in effector γδ T cells without the intervention of DCs. Activated memory αβ T 
lymphocytes differentiate predominantly in Th1 effector T cells, due to the high concentration 
of IFN-γ at the site of infection. Th1 effector cells are also an important source of IFN-γ and 
other proinflammatory cytokines, which may diffuse through the basement membrane and 
activate dermal DCs and macrophages. The activation of these cells induces the production of 
high amounts of IL-12, responsible for the enhancement of the production of IFN-γ and of the 
inflammatory response. In addition, activated macrophage express important enzymes, which 
helps the permeabilization of the basement membrane. About 24-36 hours after the initiation 
of the inflammatory response, LCs cells and immature dermal DCs, which have captured 
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antigens and have been activated by cytokines produced by Th1 effector cells, may leave  the 
skin via the afferent lymphatic vessels and reach the draining lymph node, where they may 
initiate the systemic adaptive immune response by presenting the antigens to naïve T cells. 
LCs and dermal DCs complete their maturation in the draining lymph node upregulating the 
expression of MHC class II and of B7 molecules necessary for the activation of T cells. Naïve 
T lymphocytes expressing the TCRs recognizing the antigen presented by DCs, become fully 
activated and begin the differentiation in effector T cells. The effector T cells originating from 
the activation of naïve T cells by LCs and dermal DCs in the lymph node express the 
cutaneous lymphocytes antigen (CLA), a skin lymphocyte homing receptor, which allow 
them to specifically bind to the endothelial cells of the post-capillary venules of inflamed 
derma. If the infection is stopped within 36 hours, the anti-inflammatory cytokines secreted 
by phagocytes and keratinocytes, such as IL-10, and by macrophages and lymphocytes, such 
as TGF-β, replace the proinflammatory cytokines. Thus, effector T cells arriving at the site of 
infection from the draining lymph node find an anti-inflammatory environment that promotes 
the Th2 differentiation. Effector Th2 cells secrete IL-4 and IL-10, two potent anti-
inflammatory mediators, further enhancing the production of TGF-β by the surrounding cells 
and therefore increasing the anti-inflammatory milieu counteracting the inflammation process. 
Eventually, homeostasis is reached and fibroblasts are stimulated to produce new collagen to 
repair the damaged skin. 
When the infection is not completely stopped within 36 hours, high amount of IFN-γ are still 
produced in the epidermis when effector T lymphocytes arrive. The chemokines secreted 
switch to the CC class, in particular CCL5 and CCL27, which promote the influx of Th1 
lymphocytes and macrophages in the inflamed tissue. Th1 cells and macrophages become 
hyperactivated, increasing their microbicidal power and leading to a delayed type 
hypersensitivity reaction (DTH), which is characterized by the swelling of the site of 
infection. The response is further boosted by the activation of antigen-specific cytotoxic T 
lymphocytes (CTLs) and natural killers (NKs). If these mechanisms fail to clear the pathogen, 
a switch to a Th2 response is induced by the production of IL-10 by macrophages and by high 
amounts of IL-4 secreted by mast cells. The Th2 lymphocytes may help B cells in the fight 
against the infection and they may also recirculate to the draining lymph node, where they 
interact directly with the antigen producing B cells. In case that the pathogen is not 
completely removed from the body, the infection persists and eventually generates a disease. 
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1.4 The Toll-like receptor family 
 
The Toll receptor family was originally discovered in Drosophila and found to play an 
important role in embryonic development. However, in 1996, it has been demonstrated that 
mutant flies for Toll receptor family members were highly susceptible to fungal infection. 
These findings placed the Toll receptor family between the molecular mechanisms essential in 
the innate immune system. Later, homologues to the Toll family in the Drosophila were 
discovered in mammals and named Toll-like receptors. Functional analysis of mammalian 
TLRs has demonstrated that they belong to the PRRs family, which recognize conserved 
microbial molecular pattern, the PAMPs8. 
 
Table 1: TLR recognition of microbial components. 
 
ND: not determined. (Akira, S., Uematsu, S., Takeuchi, O., 2006, Pathogen Recognition and Innate Immunity, 
Cell 124, 783-801) 
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TLRs are broadly expressed on different immune and non immune cell types, such as 
macrophages, dendritic cells, keratinocytes or fibroblasts. Their expression on these cells is 
modulated by a variety of stimuli, in particular cytokines, environmental stressors or 
pathogens. TLRs may be expressed extracellularly (TLRs 1, 2, 4, 5 and 6) or in intracellular 
compartments (TLRs 3, 7, 8 and 9). Intracellular TLRs recognize mainly nucleic acids that 
require internalization in the cell, notably in the endosome. In contrast, extracellular TLRs are 
able to bind a broad range of PAMPs, from lipopeptides to mannan and fibrinogen (Table 1). 
To date, 11 members of this family have been described in humans. 
 
 
Figure 4: TLRs signaling pathway. Each TLR family member has its specific signaling pathway. MyD88-
dependent pathway is characteristic of all the TLR family members except for TLR3. It is a common pathway to 
induce inflammatory cytokines. In addition, TLR3 and TLR4 possess TRIF-dependent pathway. TLR7, TLR8 
and TLR9 also have a specific pathway to induce IFN-α in plasmacytoid DCs. (http://www.biken.osaka-
u.ac.jp/act/act_akira_e.php) 
 
As previously explained, TLRs are important in the initiation of the inflammation process in 
the skin, but also in others tissues. In fact, recognition of PAMPs by TLRs induces the 
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production of proinflammatory cytokines and chemokines, which may increase the influx of 
leukocytes in the inflamed tissue. Moreover, in APCs, TLRs induce phagocytosis of antigens 
and their presentation to T lymphocytes. 
TLRs are transmembrane receptors, with an extracellular leucin rich repeats (LRRs) domain 
and a cytoplasmic Toll/IL-1 receptor (TIR) domain, homologue to the IL-1 receptor. The 
TLRs signaling pathway consists in a myeloid differentiation factor 88 (MyD88) dependent 
pathway, common to all the TLRs, and a MyD88-independent pathway peculiar of TLR3 and 
TLR4 (Fig. 4). After ligand binding, TLRs undergo a conformational change required for the 
association with the MyD88 adaptor molecule. Next, MyD88 recruits IL-1 receptor-associated 
kinase (IRAK), which is activated by phosphorylation and then associates with TNF receptor-
associated factor 6 (TRAF6). This leads to the activation of the nuclear factor-κB (NF-κB) 
pathway that eventually activates the proinflammatory cytokine gene transcription. 
In addition to the NF-κB pathway, the JNK pathway and the interferon regulatory factor 5 
(IRF-5) may also be activated by the MyD88 dependent pathway and modulate the 
proinflammatory cytokine gene expression (Not shown on Figure 4)8. 
The TIR domain-containing adaptor inducing IFN-beta (TRIF) dependent pathway is 
particular of TLR-3 and TLR-4 signaling. TRIF interacts with the receptor-interacting protein 
1 (RIP 1) which is responsible of the activation of the NF-κB pathway9. On the other hand, 
TRIF may also activate TANK-binding kinase 1 (TBK1) and direct phosphorylate IRF-3 and 
IRF-710, which may be translocated in the nucleus and induce the expression of the type I 
IFNs genes. In plasmacytoid dendritic cells, it exists a specific pathway for TLR-7, TLR-8 
and TLR-9. This signaling is MyD88 dependent and leads to the induction of IFN-α gene. In 
contrast with the induction of IFN-inducible genes by TLR-3 and TLR-4, this pathway is 
TRIF and TBK1 independent. 
 
1.5 The nucleotide-binding oligomerization domain family 
 
As previously discussed, microbial PAMPs are recognized by specific host PRRs, such as 
TLRs. The nucleotide-binding oligomerization domain receptors (NODs) are also members of 
the PRRs family. In contrast with TLRs, NOD family members are cytosolic soluble receptors 
in charge of the recognition of peptidoglycan (PGN) derived molecules not recognized by 
TLRs. NOD1 (which is encoded by the caspase recruitment domain 4 gene, CARD4) and 
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NOD2 (which is encoded by the caspase recruitment domain 15 gene, CARD15) are mainly 
expressed by APCs and mucosal epithelial cells. These cell types are exposed under 
physiological conditions to bacterial PGN and involved in the response to commensal 
organisms. Recent studies have also highlighted the involvement of CARD15 in the 
pathogenesis of Crohn’s disease, while CARD4 was associated with inflammatory bowel 
disease11. 
NOD1 and NOD2 are composed of three main domains. The LRR domain, similar to the LRR 
of TLRs, which is involved in the ligand recognition, a central NOD domain, responsible of 
the self oligomerization and possessing an ATPase activity, and an amino-terminal domain 
composed of caspase recruitment domains (CARD), in charge of the initiation of the signaling 
(Fig 5)12. Although initial studies have reported lipopolysaccharide (LPS) as a NOD2 ligand, 
it is now clear that NOD1 and NOD2 detect respectively PGN derived γ-D-glutamyl-meso-
diaminopimelic acid (iE-DAP) and PGN derived muramyl dipeptide (MDP). MDP is found 
both in Gram-positive and Gram-negative PGN. This designates NOD2 as a general sensor of 
most bacteria. In contrast, iE-DAP is a specific component of Gram-negative PGN, meaning 
that NOD1 mainly sense Gram-negative bacteria. The recognition of NOD1 and NOD2 
ligands is done by the LRR domain, which consequently activates the NOD and CARD 
domain. Then, a CARD containing serine/threonine kinase (the receptor-interacting 
serine/threonine kinase, RICK) is recruited and physically associated with the CARD domain 
by a CARD-CARD interaction. In the case of NOD2, RICK activation leads to the 
polyubiquitylation of IKKγ, followed by phosphorylation of IKKβ and of IκB, resulting in the 
release of NF-κB. Finally, NF-κB may translocate to the nucleus, where it may act on the 
inflammatory gene transcription (Fig 5). The signaling pathway of NOD1 is not well studied. 
However, the activation of RICK by NOD1 also leads to the activation of NF-κB and to the 
modulation of the inflammatory genes transcription. 
In addition to this signaling pathway, NOD1 and NOD2 may also activate the mitogen-
activated protein kinases (MAPK) pathway by an as yet unknown mechanism. 
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Figure 5: Signaling pathway of NOD1 and NOD2. PGN: Peptidoglycan; iE-DAP: γ-D-glutamyl-meso-
diaminopimelic acid; MDP: muramyl dipeptide (Strober, W., Murray, P.J., Kitani, A., Watanabe, T., 2006, 
Signaling pathway and molecular interactions of NOD1 and NOD2, Nature Reviews Immunology, 6 (1), 9-20). 
 
1.6 Cytokines 
 
Cytokines are small water-soluble proteins and glycoproteins released mainly by leukocytes 
and which have an important role in the innate and adaptive immune response. In general, 
cytokines are involved in the regulation of three major homeostatic mechanisms: the innate 
immune response, the adaptive immune response and the growth and differentiation of 
hematopoietic cells. The structure of cytokines is varied and members similar in structure may 
have completely different effects. For instance, interleukin 10 (IL-10) and interleukin 12 (IL-
12) possess the same structural motif, a long chain 4 α-helix, but their effects are opposite. In 
fact, IL-10 has anti-inflammatory activity, whereas IL-12 is a proinflammatory cytokine. 
In general, cytokines and chemokines are not expressed under physiological conditions, but 
they are synthesized by activated leukocytes in response to a microbial or viral product. 
Moreover, the half-life of cytokines mRNA and proteins is very short. Therefore, after 
stimulation by pathogens a wave of cytokines is secreted, followed by the return to the resting 
condition in case of absence of a new stimulus. Cytokines generally exert their effects in a 
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paracrine or autocrine manner and their effects depend on the expression of cytokine 
receptors on target cells. Frequently, cytokines possess pleiotropic or redundant effects. 
Furthermore, the expression of a cytokine may also induce or repress the expression of other 
cytokines and receptors, resulting in an enhanced or inhibited response to a stimulus. 
Hereunder, the properties of eight important cytokines, namely IL-4, IL-6, IL-10, IL-12, IL-
17, IL-23, IFN-γ and TGF-β are discussed in detail. 
 
a) IL-4 
IL-4 is a pleiotropic cytokine mainly secreted by Th2 cells, but also by mast cells, basophils 
and Natural Killers T (NKT) cells. The IL-4 receptor is widely expressed and consequently 
IL-4 influences all cell types. This cytokine possesses antagonistic effects to IFN-γ on Th 
cells13. In fact, it promotes Th2 cells differentiation and growth, while inhibiting the Th1 
development. Moreover, IL-4 (formerly know as B cell-growth-factor) supports also B cell 
growth and differentiation and it induces the upregulation of MHC class II and CD23. This 
promotes the development of the humoral immune response in charge of fighting against 
extracellular pathogens. IL-4 is also important for the antibody isotype switching to IgG1 and 
IgE while it inhibits the production of IgG2a. Consequently, IL-4 is involved in the allergic 
response by supporting the IgE-mediated mast cells degranulation. In general, IL-4 possesses 
anti-inflammatory properties and inhibits the production of proinflammatory cytokines, 
chemokines and adhesion molecules by macrophages. However, IL-4 may also activate a 
negative feedback mechanism that induces production of IL-12 in DCs and macrophages. 
 
b) IL-6 
Similarly to IL-4, IL-6 is a multifunctional cytokine, which is primarily secreted by 
mononuclear phagocytes, fibroblasts, vascular endothelial cells and some activated T cells in 
response to IL-1 and TNF. IL-6 plays a role in inflammation, adaptive immune response, 
hematopoiesis, nervous and endocrine mechanisms. IL-6 is also crucial for the acute phase 
response by inducing the production of acute phase proteins and stimulating pathogen 
clearance by neutrophils. Moreover, IL-6 supports the differentiation and maturation of B and 
T cells, macrophages, megakaryocytes, osteoclasts and some neurons. IL-6 receptor (IL-6R) 
consists in two subunits: IL-6Rα and gp130. IL-6Rα is in charge of the binding of IL-6 while 
the gp130 chain mediates signal transduction via Jak1, Jak2 and Tyk2. These kinases may 
recruit and activate various signal transducers and activators of transcription (STATs), which 
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may translocate to the nucleus and activate additional IL-6-inducible genes implicated in the 
acute phase response. IL-6 has been reported to be implicated in many different diseases. For 
instance in chronic inflammatory bowel diseases, IL-6 is known to activate the STAT3 
transcription factor, which results in a T cell resistance against apoptosis14. Moreover, in 
synovial fluid from rheumatoid arthritis patients IL-6 activity is significantly increased 
compared to control patients15. 
 
c) IL-10 
IL-10 is an anti-inflammatory cytokine induced not only by pathogen invasion but also by the 
presence of others proinflammatory cytokines, such as IL-6, IL-12, TNF-α and type I IFNs. 
IL-10 is mainly secreted by activated monocytes, macrophages and Th2 cells but also by non-
immune cells, such as keratinocytes and hepatocytes. The primary function of IL-10 is to 
counteract proinflammatory cytokines by inhibiting NF-κB-activated transcription of 
proinflammatory genes, notably of IL-1, IL-6, IL-8 and IL-12. Moreover, IL-10 promotes Th2 
differentiation while inhibiting IFN-γ and IL-2 secretion. In addition, IL-10 inhibits the 
expression of MHC class II, B7-1 and B7-2 molecules on APCs cells further reducing the 
CD4+T cell response1. 
 
d) IL-12 
IL-12 is the main proinflammatory cytokine secreted by activated macrophages and in a 
minor amount by neutrophiles, DCs, monocytes and B cells. IL-12 is composed of two 
subunits, p35 and p40, which is shared with IL-23. The main effects of IL-12 are: a) 
Promotion of the differentiation of naïve T cells in IFN-γ producing Th1 cells; b) Induction in 
synergy with IL-18 of the secretion of IFN-γ by activated Th1 cells and NK cells; c) 
Stimulation of the cytolytic activity of activated CD8+ and NK cells; d) Enhancement of the 
production of Ig2a associated with Th1 response while inhibiting the other Th2 isotypes. A 
deregulated production of IL-12 has also been associated with the development of Th1-
mediated diseases, such as Crohn’s disease and multiple sclerosis16,17. 
 
e) IL-17 
IL-17 is exclusively produced by a subpopulation of activated memory CD4+ T cells and its 
expression is regulated by IL-23, IL-6 and TGF-β. IL-17 is well known for its 
proinflammatory effects, in particular it is involved in the induction of IL-6, IL-8 and G-CSF 
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by keratinocytes, fibroblasts and epithelial cells18. Moreover, IL-17 mediated production of 
IL-8 has been associated with the recruitment of immune cells to peripheral tissues during 
inflammation. However, IL-17 does not seem to regulate T cells function. Recent studies have 
correlated overexpression of IL-17 with several proinflammatory mediated diseases in 
humans, such as rheumatoid arthritis, multiple sclerosis and asthma19,20. 
 
f) IL-23 
IL-23 is a heterodimeric cytokine composed of a p19 subunit and a p40 subunit shared with 
IL-12. The majority of IL-23 is produced by activated DCs. However, there is also evidence 
of production of IL-23 by keratinocytes, which may contribute to the cutaneous inflammatory 
response21. Recent studies have also highlighted the implication of IL-23 in the differentiation 
of the newly discovered Th17 cells. In fact, it seems that IL-23, in combination with IL-6 and 
transforming growth factor beta (TGF-β), may enhance the development of IL-17 producing 
T cells, which are implicated in the clearance of extracellular pathogen and autoimmunity22. 
 
g) IFN-γ 
IFN-γ is mainly produced by activated Th1 cells and in minor amounts by CTLs and NK 
cells. As the type I IFNs, IFN-γ possesses antiviral and antiproliferative activities. In fact, it is 
able to induce in target cells an antiviral state, which is characterized by the production of 
proteins able to interfere with virus replication. Moreover, IFN-γ may inhibit cell growth, 
restraining by this way the expansion of infected cells. In addition to these effects, IFN-γ is 
also able to activate other immune cells, such as macrophages, which increase their 
inflammatory cytokines production and pathogen elimination. Furthermore, IFN-γ may 
enhance MHC class I and II and B7 molecules expression on APCs promoting T cell 
activation. Moreover, it inhibits the production of IL-4 and IL-17 triggering Th1 
development13. 
 
h) TGF-β 
TGF-β exists in three distinct isoforms; TGF-β1, TGF-β2 and TGF-β3, derived from three 
distinct genes. TGF-β molecules are synthesized mainly by hematopoietic cells, such as T and 
B cells, DCs and macrophages, but also by some non-hematopoietic cells. TGF-β1 is the main 
product of these cells, but all three cytokines signal through the same receptor and possess 
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practically an identical function. TGF-β molecules are pleiotropic and play a role in adhesion, 
proliferation, differentiation, transformation, chemotaxis and immunoregulation. In particular, 
TGF-β1 inhibits the proliferation of activated T cells and promotes the development of the 
regulatory T cells lineage (Treg), which is immunosuppressive. TGF-β1 inhibits also 
macrophages activation, Ig production, MHC class II expression and cytotoxic activities. 
Moreover, it may block the effects of proinflammatory cytokines and downregulates the 
production of IL-1, IL-2, IL-6, IFN-γ and TNF23. 
 
1.7 T-helper-cell lineage development 
 
As previously mentioned, as soon as a pathogen succeeds in entering the body, an immune 
response is triggered. Antigens derived from the pathogen may be recognized by PRRs 
expressed on different cells types, which may be activated and increase their production of 
proinflammatory cytokines boosting the inflammatory reaction. Moreover, APCs, notably 
DCs, may also capture antigens and present them in association with MHC class I and II 
complexes to naïve T cells after migration to the draining lymph node. During migration, DCs 
become fully mature and increase the expression of adhesion molecules and their ability in 
presenting antigens. The upregulation of adhesion molecules is essential to establish strong 
interactions with naïve T cells and consequently to promote recognition of the antigen 
presented on the MHC complex1. 
Full activation of naïve T cells in lymph nodes by APCs requires three different signals1. The 
first signal is the binding of the antigen presented on MHC class I or II to the specific T cell 
receptor (TCR). A minimum threshold of TCR-MHC contacts has to be reached for activation 
of naïve T cells. These interactions induce an internal rearrangement of the T cell 
cytoskeleton, allowing the redistribution of the surface receptors nearby the interface between 
the two cells. This increases the probability of T cell and DCs contact. The second signal 
necessary for the full activation of naïve T cells is the binding of co-stimulatory molecules. 
These molecules are expressed on APCs and usually may decrease the threshold required for 
T cells activation or enhance the TCR-MHC signal. The most important co-stimulatory 
interaction is the CD28-B7 couple. B7 ligands are expressed on APCs and recognized by 
CD28 receptors expressed on T cells. The binding of B7 on the CD28 leads to the production 
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of important cytokines, such as IFN-γ, IL-10 and IL-6. In addition, this binding induces 
certain signaling pathways, such as the MAP kinases pathway. 
The third signal required is the binding of cytokines on the upregulated receptors on the now 
activated T cells. These cytokines are responsible for T cell survival, proliferation and finally 
differentiation in effector T cells. 
The differentiation of T helper cells in Th1, Th2, Th17 or T regulatory (Treg) cells depend in 
fact on the cytokines milieu (Fig 6)22,24. 
 
 
Figure 6: T helper cells differentiation. The differentiation of T helper cells in Th1, Th2, Th17 or Treg cells 
depend on the cytokines milieu. (Tato, C.M., O’Shea, J.J. 2006. What does it mean to be just 17? Nature 441, 
166-168). 
 
a) Th1 cells 
Th1 cells develop from undifferentiated CD4+ T helper cells (Th0) in a IL-12-rich 
environment. The binding of IL-12 to its receptor on Th0 cells triggers intracellular signaling, 
which eventually induces the activation of STAT-4. This transcription factor may translocate 
to the nucleus, where it induces the expression of Th1 genes, including IFN-γ. Moreover, 
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another transcription factor, “T-box expressed in T cells” (T-bet), is also induced and 
promotes the Th1 development inhibiting meanwhile Th2 cell differentiation by preventing 
the expression of GATA-3 transcription factor25,26. IFN-γ also contributes in the upregulation 
of T-bet transcription factor and in the inhibition of Th17 development. Th0 cells do not 
produce IL-12, therefore the cytokines milieu necessary for Th1 differentiation depends on 
the presence of activated APCs producing IL-12 close to the Th0 cells. Mature Th1 cells 
promote the defense against intracellular pathogen primarily by secreting cytokines in charge 
of sustaining the cellular adaptive immune response1. In particular, Th1 cells produce 
cytokines, especially IFN-γ and IL-2, essential for activation and proliferation of CD8+ T 
cytotoxic cells. These cells may recognize antigens, mainly presented on MHC class I 
complex, on target cells and induce their apoptotic death by Fas killing, cytotoxic granule 
release or secretion of cytotoxic cytokines. Moreover, IFN-γ and other cytokines secreted by 
Th1 lymphocytes improve the activation of macrophages, which increase their cytokines 
production and phagocytic ability. Th1 cells also supply the CD40L and IFN-γ necessary for 
the switch to the production of Ig isotypes implicated in the complement activation. It has 
also been demonstrated the involvement of Th 1 cells in the pathogenesis of organ specific 
autoimmune diseases such as rheumatoid arthritis and psoriasis27. 
 
b) Th2 cells 
In contrast with Th1 cells, to differentiate Th2 cells need a IL-4 rich milieu. Binding of IL-4 
to its receptor on Th0 cells induce the activation of STAT-6 via the Jak1 and Jak6 kinases. 
STAT-6 may upregulate the expression of another transcription factor, GATA-3, which is 
responsible of the inhibition of the expression of T-bet, IFN-γ and IL-12 receptor (IL-12R), 
consequently inhibiting the development of Th1 cells. Moreover, GATA-3 may also induce 
the expression of Th2 cytokines such as IL-4, IL-5, IL-10 and IL-13. It has been demonstrated 
that GATA3 may also be induced by CD28 signaling independently from STAT-6 and IL-4. 
However, it is still not clear how this signaling works25,26. Another transcription factor, 
important for Th2 differentiation, is c-maf. C-maf is expressed exclusively in maturing and in 
fully differentiated Th2 cells. This transcription factor works in association with the 
transcription factor c-jun inducing the synthesis of IL-4 meanwhile inhibiting the expression 
of IFN-γ and Th1 cells. IL-4 also inhibits the development of Th17 cells. The principal source 
of IL-4, essential for Th2 development, are activated mast cells and NKT cells present in the 
proximity of activated Th2 cells and Th2 cells themselves. Mature Th2 cells promote the 
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defense against extracellular pathogens and parasites, mainly by inducing a humoral adaptive 
immune response. The cytokines secreted by Th2 cells sustain B cells activation and 
production of Th2 antibody isotypes like IgA, IgE and IgG1. These isotypes are less efficient 
in promoting complement activation but they may induce the neutralization of antigens 
without triggering the inflammation process. In addition, IL-5 produced by Th2 cells is also in 
charge of the activation of eosinophiles, which are crucial for parasite elimination. Others Th2 
cytokines may also collaborate to regulate immune cells activation and proliferation. IL-3, IL-
4 and IL-10 stimulate mast cells activation and proliferation. Moreover, IL-10 inhibits 
macrophage effector function, MHC II expression, IL-12 production, B7 expression, while 
increasing MHC class II on B cells. IL-4 may also increase the expression of MHC class II on 
APCs and simulate B cells proliferation while inhibiting, in collaboration with IL-13, 
proinflammatory cytokines production1. 
A defect in the balance of Th cells development in favor of Th2 cells has also been correlated 
with the pathogenesis of allergic diseases such as asthma, eczema and rhinitis28. 
 
c) Th17 cells 
Th17 cells are a newly discovered lineage of effector CD4+ T cells characterized by the 
production of IL-17. Recent studies have demonstrated that TGF-β and IL-6 are crucial for 
the differentiation of naive T cells into Th17 cells. Moreover, IL-23 has also been involved in 
the proliferation of activated and memory Th17 cells but not of naïve T cells18,29. In fact, the 
IL-23 receptor is not expressed on Th0 cells but it is induced by TGF-β only on effector Th17 
cells. TGF-β has also a dual function in the differentiation of Th cells. In fact, TGF-β alone 
induces the differentiation of Treg cells, whereas in combination with IL-6 it induces the 
development of Th17 cells, while inhibiting the expression of the Treg transcription factor 
Foxp330. The differentiation of Th17 cells is independent of the transcription factors STAT-4 
and STAT-6 which regulate the differentiation of Th1 and Th2 cells, but it involves the 
transcription factor STAT-3. STAT-3 is activated by both IL-6 and IL-2331. The binding of 
these interleukins on their receptors on naïve T cells induces phosphorylation of STAT-3, 
which may translocate to the nucleus and promote the expression of IL-17 gene. The action of 
TGF-β, IL-6 and IL-23 is antagonized by IFN-γ and IL-4 produced during the Th1 and Th2 
development respectively. It has been demonstrated that Th17 cells are involved in the 
immune response against extracellular bacteria and parasitic worms. However, IL-17 has been 
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associated also with autoimmune disease and cancer29,32. Some studies have demonstrated the 
ability of preventing autoimmune disease in mice by treatment with antibody anti IL-17. 
 
d) Treg cells 
Treg cells are a particular subset of Th cells in charge of controlling the immune response and 
establishing self-tolerance by immunosuppression. CD4+CD25+ Treg cells are a well known 
Treg subpopulation constitutively expressing the IL-2Rα chain (CD25). They develop from 
Th0 cells in case of antigen presentation by immature DCs and under a TGF-β 
microenvironment and are characterized by the expression of the transcription factor Foxp3. 
After activation, CD4+CD25+ Treg cells do not proliferate and do not secrete significant 
amount of cytokines. In contrast, they are able to suppress the proliferation and the IL-2 
production of other effector T cells in a non specific manner by direct intercellular contact. 
However, the surface molecules engaged in this process have not yet been characterized. It 
has also been demonstrated that humans and mice lacking the Foxp3 transcription factor lack 
Treg cells and develop more autoimmune diseases than wild type animals33. 
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2. Neuroimmunomodulation 
 
The nervous system and the immune system are two major adaptive system of the body. For 
many years the immune system was thought to be autonomous and independent from the 
influence of other systems. However, during the last 30 years, researchers have provided 
strong evidence of a cross-talk between these two systems primarily via the autonomic 
nervous system (ANS) and the hypothalamic-pituitary-adrenal axis (HPA). The influence of 
adrenergic agents on lymphocytes proliferation34 and the effect of inflammatory cytokines on 
plasma corticosteroids level35 may be considered as milestones in the field. Later, other 
studies have provided evidence of an altered immune function following classical behavioural 
conditioning36 and stressful stimuli37,38. 
 
2.1 The sympathetic nervous system 
 
The ANS is independent of the conscious control and in vertebrates innervates practically all 
tissues and organs, except skeletal muscle fibers. It is divided in three components: the 
sympathetic nervous system (SNS), the parasympathetic nervous system (PANS) and the 
enteric nervous system, which is related to the gastrointestinal tract and regulates intestinal 
functions. The enteric nervous system is also modulated by the SNS and the PANS. The SNS 
is composed of preganglionic and postganglionic sympathetic fibers. The former originate in 
brain nuclei and leave the central nervous system via the thoracic and lumbar spinal nerves to 
terminate in para- and pre-vertebral ganglia. The latter originate in ganglia and innervate the 
tissues. Preganglionic fibers are cholinergic fibers, which release acetylcholine (ACh) in the 
ganglia. On the contrary, postganglionic fibers are noradrenergic fibers, which release 
catecholamines (CAs), predominantly norepinephrine (NE) (Fig. 7). Another component of 
the sympathetic nervous system is the adrenal medulla. As the sympathetic ganglia, the 
adrenal medulla originates from the neural crest and is innervated by cholinergic fibers. 
However, the main product released by this organ is epinephrine (E), which has systemic 
effects, and just to a lesser extent NE. In the parasympathetic nervous system both pre- and 
post-ganglionic fibers release ACh39. 
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Figure 7: The autonomic nervous system. The sympathetic nervous system is composed of preganglionic 
cholinergic fibers and postganglionic noradrenergic fibers. Opposite, the parasympathetic nervous system is 
composed of pre- and post-ganglionic cholinergic fibers. The enteric nervous system is not represented. (Purves, 
D., Augustine, G.J., Fitzpatrick, D., Katz, L.C., LaMantia, A.S., McNamara, J.O., 1999. Neurosciences, 
DeBoeck Université). 
 
The synthesis of NE takes place in the noradrenergic ending, where tyrosine is transported by 
a sodium dependent carrier. At that place tyrosine is converted first in 
dihydroxyphenylalanine and next in dopamine (DOPA) by the enzymes tyrosine hydroxylase 
and DOPA decarboxylase, respectively. DOPA is then transported in the synaptic vesicles, 
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where it is converted to NE by the dopamine-β-hydroxylase. In the adrenal medulla, NE is 
further transformed in E by the phenylethanolamine N-methyltransferase enzyme. 
NE and E mediate their effects through the adrenergic receptors (ARs). ARs are seven-chain-
transmembrane receptors belonging to the class of G-protein coupled receptors. They are 
subdivided in three major types: α1- α2- and β-ARs. α1−ARs are further divided in the  α1A, 
α1B, and α1D subtypes; α2-ARs in the α2A, α2B and α2C subtype and finally β−ARs are 
subdivided in β1, β2 and β3 subtypes. 
The affinity of NE and E for these receptors varies depending on the subtype considered 
(Table 2). 
 
Table 2: Subdivision of adrenergic receptors and their transduction mechanism 
Receptor 
subtype 
Agonist potency 
order 
Transduction 
mechanism 
Agonist Antagonist 
 
α1 
 
NE > E 
Activates Gp/q, ↑IP3, 
↑ Ca2+ 
Phenylephrine, 
Metoxamine, Cirazoline 
Phenoxybenzamine, 
Phentolamine, Prazosin, 
Tamsulosin, Terazosin 
 
α2 
 
E > NE 
Activates Gi/o, 
inhibition adenylate 
cyclase, ↓ cAMP 
Clonidine, Lofexidine, 
Xylazine, Tizanidine, 
Guanfacine 
 
Yohimbine 
 
β1 
 
NE > E 
Activates Gs, 
activation adenylate 
cyclase, ↑ cAMP 
 
isoprenaline, dobutamine 
Metoprolol, atenolol, 
betaxolol 
 
β2 
 
E > NE 
Activates Gs, 
activation adenylate 
cyclase, ↑ cAMP 
Salbutamol, Bitolterol 
mesylate, formoterol, 
isoproterenol, levalbuterol, 
metaproterenol, salmeterol, 
terbutaline, ritodrine 
 
Butoxamine, ICI 
118,551 
 
β3 
 
NE > E 
Activates Gs, 
activation adenylate 
cyclase, ↑ cAMP 
 
BRL-37344 
 
bupranolol 
NE: norepinephrine; E: epinephrine; Gs/i/p/q: G proteins; IP3: inositol 1, 4, 5-triphosphate; cAMP: cyclic 
adenosine 5’-monophosphate. (Elenkov, I.J., Wilder, R.L., Chrousos, G.P., Vizi, E.S., 2000. The sympathetic 
nerve- An integrative interface between two supersystems: the brain and the immune system, Pharmacological 
Reviews, 52:595-638). 
 
Primary and secondary lymphoid tissues and organs are innervated extensively by the 
sympathetic nervous system40. In general, nodular and follicular zones of developing and 
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maturing B cells are less innervated than the zones characterized by a high concentration of T 
cells, macrophages and plasma cells. It has also been demonstrated that a wide range of 
immune and non-immune cell types express ARs. In particular, β2-ARs are expressed by Th1, 
DCs, neutrophils, keratinocytes and melanocytes but not Th2 cells41,42. The effects of CAs on 
lymphoid cells via β-ARs may vary depending on the dose, timing of treatment, target cells or 
density of ARs. Several studies have demonstrated the modulation of cytokine production and 
Th development by CAs through β-ARs signaling (Table 3). 
 
Table 3: β-ARs mediated effects of CAs on cytokine and chemokine production 
 
b: CAs are probably not able to affect the production of type 2 cytokines by Th2 cells directly, simply because 
they do not express β-ARs. Indirectly, however, they may potentiate the cytokine production by Th2, since they 
remove the inhibitory restraints on these cells exerted mainly by IL-12 and IFN-γ. BCDF: B cell differentiation 
factor; TEC: Thymic epithelial cells (Elenkov, I.J., Wilder, R.L., Chrousos, G.P., Vizi, E.S., 2000. The 
sympathetic nerve- An integrative interface between two supersystems: the brain and the immune system, 
Pharmacological Reviews, 52:595-638). 
 
In particular, it has been reported that NE and E inhibit the production of the proinflammatory 
cytokine IL-12 by monocytes and DCs via β-ARs in vitro and in vivo43,44. Furthermore, β-
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ARs have also been reported to inhibit the development of Th1 cells, while promoting Th2 
cells differentiation42. Others proinflammatory cytokines, notably IL-1 and TNF-α, are also 
inhibited by β-ARs stimulation, while the production of Th2 cytokines, such as IL-10, is 
upregulated45. This provides evidence of an anti-inflammatory effect of CAs and of their 
ability in switching the adaptive immune response from the Th1 to the Th2 type. 
Interestingly, IL-6, a cytokine of the acute phase response and responsible in collaboration 
with TGF-β of the Th17 development, is also upregulated by CAs46. This may indicate an 
involvement of the SNS not only in the Th1/Th2 development but also in the induction of the 
Th17 differentiation. 
 
2.2 The hypothalamic-pituitary-adrenal axis 
 
The HPA axis is composed by the hypothalamus, a brain region, and by two endocrine 
glands, the pituitary gland and the adrenal cortex. Exposure to proinflammatory stimuli as 
well as to physical or psychological stress results in activation of the HPA axis and, as a final 
consequence, in the release of glucocorticoids, cortisol in humans and corticosterone in mice. 
After stimulation, neurons originating in the paraventricular nucleus of the hypothalamus 
secrete the corticotropin-releasing hormone (CRH) in the hypophysial portal circulation. 
Next, CRH stimulates the secretion of the adrenocorticotropic hormone (ACTH) by the 
anterior pituitary gland. Then, ACTH acts on the adrenal cortex stimulating the release of 
endogenous glucocorticoids (Fig. 8). 
 
Figure 8: HPA axis. The secretion of CRH by the hypothalamus induces the release of ACTH by the pituitary 
anterior gland. This stimulates the secretion of glucocorticoids by the adrenal cortex. CRH: corticotropin-
releasing hormone; ACTH: adrenocorticotropic hormone. 
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Glucocorticoid receptors (GRs) are cytosolic steroids receptors, which translocate to the 
nucleus upon activation by ligand binding. In the nucleus, activated GRs may modulate 
directly the glucocorticoid sensitive gene or interact with NFκB or AP-1 transcription factors. 
GRs are widely expressed throughout the body; therefore glucocorticoids have effects on 
practically every system. In particular, they possess modulatory properties on the immune 
system. It has been demonstrated that in vivo injection of dexamethasone, a synthetic 
glucocorticoid, impairs the production of proinflammatory cytokines, notably IL-1β and TNF, 
by thymic DCs47. Moreover, dexamethasone inhibits the LPS induced production of IL-12 by 
human monocytes48. Opposite, glucocorticoids have been reported to improve the production 
of anti-inflammatory cytokines, such as IL-10 and IL-4, by dendritic cells and macrophages49. 
Cell adhesion molecules and chemokines are also inhibited by glucocorticoids, therefore 
reducing the immune cell trafficking at the site of inflammation50. Together, these results 
provide evidence of anti-inflammatory and immunosuppressive properties of glucocorticoids. 
An altered function of the HPA axis has been associated with many different diseases. In 
humans, rheumatoid arthritis, irritable bowel disease and fibromyalgia are all characterized by 
an augmented immune response associated with an impaired HPA-axis function. On the other 
hand, excess in HPA-axis activity, often due to chronic stress, results in an increase 
susceptibility to infections and prolonged wound healing. 
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3. Aim of the study 
 
Previous studies performed in our laboratory reported that NE may affect LCs migration and 
exert a chemotactic action on bone marrow derived DCs. This effect was mediated by the α1-
ARs and may influence the contact hypersensitivity response (CHS)51. Further studies in our 
laboratory provided evidence of the influence of the local sympathetic nervous system on the 
Th differentiation in response to an antigen. In fact, these studies demonstrated that NE 
inhibits the LPS induced IL-12 production by DCs, while increasing the production of the 
anti-inflammatory cytokine IL-10. The NE effect was mediated by β- and α2-ARs. Moreover, 
adoptive transfer of NE exposed DCs promote a Th2 differentiation52. 
These results have been confirmed by other authors. Seiffert et al. have confirmed that E and 
NE could inhibit LCs antigen presentation during CHS. This effect was removed by the use of 
the β2-ARs antagonist ICI 118,551. In addition, they showed that LCs express α1A- and β-
ARs mRNA53. Recently, other studies in our laboratory showed that LCs migration and CHS 
response are increased in mice treated with the β2-ARs antagonist ICI 118,551 during FITC 
sensitization54. Moreover, this study demonstrated that maturing bone marrow DCs express 
β1-, β2-, α2A-, and α2C-ARs genes and that β2- and α2A-ARs are involved in the reduced 
production of IL-12, while only β2-ARs stimulated IL-10. Most recently, it has also been 
demonstrated an involvement of β2-ARs in dendritic cells based cancer vaccine. Adoptive 
transfer of immature DCs loaded with ovalbumin (OVA) after intradermal injection of PGN 
along with a β2-ARs antagonist, increased the antitumor response and significantly reduced 
the tumor growth. This effect was mediated by an increased DCs migration to the draining 
lymph node, which resulted in a modulation of the OVA specific cytotoxic T lymphocyte 
response55. 
In summary these findings suggest a sympathetic nervous regulation of the innate and the 
adaptive immune response via β-ARs. The local release of catecholamines may influence 
DCs antigen presentation ability, cytokines production and consequently Th cell priming 
properties. 
On the basis of the previous studies, the aims of this project are: 
a) To investigate in vivo the possible influence of β-ARs blockade on the pro- and anti-
inflammatory cytokine production upon TLRs activation in mice skin. 
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b) To investigate whether the possible β-ARs effects on cytokine production may affect 
DCs migration to the draining lymph node and the consequent Th priming during the 
adaptive immune response to a soluble protein. 
c) To detail in vitro the modulation of the DC cytokines production by NE upon different 
PRRs activation. 
d) To test the effects of salivary glands extract (EGS) from the tick Ixodes ricinus on 
pDCs migration. 
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II. Materials and methods 
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Mice 
Balb/c (H-2d) and C57/Bl6 (H-2b) inbred mice were purchased from Harlan, Udine, Italy. β2-
AR gene deficient (β2ko) mice (H-2q) were a generous gift of Prof. Brian Kobilka, Stanford 
University, USA. All mice were maintained in our animal colony under specific pathogen-
free conditions, food and water ad libitum and under a standard 12 hours photoperiod at a 
constant temperature of 21°C. Six- to ten-week-old female mice were used for all 
experiments. All experiments were authorized by the local veterinary authority. 
 
Skin treatment and drugs 
Mice were injected intradermally in the shaved back with a β-adrenergic antagonist. Notably, 
propranolol (PRO, β-adrenergic antagonist, 5µg/mouse, Sigma, St. Louis, USA) and ICI 
118,551 hydrochloride (ICI, β2-adrenergic antagonist, 5µg/mouse, Tocris bioscience, 
Ellisville, USA) were used. Control mice were injected with phosphate buffered saline alone 
(PBS 1X pH 7.2, 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4). The 
skin was collected 3 hours after the injection and stock overnight at 4°C in RNAlater 
(Ambion Inc., Austin, USA). 
 
Epidermal and dermal sheet separation 
In order to evaluate a possible different TLRs gene expression between derma and epidermis, 
skin from Balb/c mice was cut into 3-5 mm wide ribbons and incubated in dispase 5U/ml 
(Roche Diagnostics, Basel, Switzerland) supplemented with 0.375% trypsin (Sigma) for 1 
hour at 37°C. The dorsal part, corresponding to the epidermal sheets, was peeled away using a 
sterile forceps. Both, epidermal and dermal sheets, were washed with PBS 1X pH7.2 and then 
stocked in RNAlater at 4°C. 
 
Cells 
Bone marrow cells from C57/Bl6 (H-2b) mice were cultured in 10cm petri dishes at 
0.25.106cells/ml in 10ml complete culture medium: RPMI 1640 (Gibco, Karlsruhe, Germany) 
supplemented with 10% (v/v) heat-inactivated foetal calf serum (FCS, Bioconcept, Allschwil, 
Switzerland), 2mM L-glutamine (L-Glut, Bioconcept), 100U/ml Penicillin (Bioconcept), 
100µg/ml Streptomycin (Bioconcept), 25mM Hepes buffer (Gibco), 50µM 2-mercaptoethanol 
(2-ME, Sigma) and 30ng/ml GM-CSF (ReliaTech Gmbh, Braunschweig, Germany). On day 
Michela Manni Institut de Biologie Université de Neuchâtel 
 43 
2, 10ml of fresh medium was added. On day 4 and 7, 10ml of medium was replaced with 
fresh culture medium. DCs were used on day 9. 
XS52 cell line is a long-term Langerhans cell-like cell line established from newborn 
epidermis. The XS52 cells are cultured in complete culture medium: RPMI 1640 (Gibco), 
supplemented with 10% (v/v) heat-inactivated FCS (Bioconcept), 2mM L-Glut (Bioconcept), 
100µM nonessential amino acids (Gibco), 100U/ml Penicillin (Bioconcept), 100µg/ml 
Streptomycin (Bioconcept), 10 µM sodium pyruvate (Gibco). Finally, 10% (v/v) culture 
supernatant of a NS47 stromal cell line, cultured in complete RPMI as described above, was 
added. 
 
Cells sorting by MACS 
Dendritic cells from in vitro cultures were selected by CD11c positivity using a magnetic 
activated cell sorting (MACS) system (Miltenyi Biotech, Bergisch Gladbach, Germany). 
Briefly, non-adherent cells and loosely adherent proliferating aggregate were collected and 
washed using the buffer MACS (PBS1X pH7.2, 2mM EDTA, 1% FCS). Cell number was 
determined and cells were resuspended in 80µl Buffer MACS and 20µl CD11c (N418) 
MicroBeads (Miltenyi Biotech) per 10.106 cells and incubated 15 minutes at 8°C. Cells were 
further washed and resuspended in 500µl Buffer MACS. Cell suspension was applied onto a 
LS Column (Miltenyi Biotech) placed in a magnetic field of a MACS separator. The column 
was washed three times with buffer MACS to collect the negative cell fraction. To collect the 
positive CD11c cell fraction, the column was removed from the magnetic field and placed on 
a collection tube. 5 ml Buffer MACS were pipetted onto the column and the magnetically 
labelled cells were eluted. To increase the purity of the enriched CD11c+ cell population, the 
magnetic separation procedure was repeated using a new column. An aliquot of purified cells 
was analyzed by flow cytometry to assess the percentage of CD11c+ cells. Only populations 
with more than 95% CD11c+ cells were used for in vitro experiments. 
 
In vitro experiments 
DCs, sorted by MACS system as described above, were incubated at 106 cells/ml in a 24-well 
culture plate with a TLR ligand in presence or absence of norepinephrine (NE, Fluka, Buchs, 
Switzerland). Notably, 10µg/ml peptidoglycan (PGN, Fluka), 2µg/ml muramyl dipeptide 
(MurNAc-L-Ala-D-iso-Gln, MDP, NOD2 agonist, NeoMPS, Strasbourg, France), 10µg/ml 
N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-[R]-cyteine (PAM, TLR-2 agonist, 
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EMC microcollections Gmbh, Tuebingen, Germany), 1µg/ml lipopolysaccharide (LPS 
Sigma), a combination of PAM and MDP (10µg/ml PAM+ 2µg/ml MDP) and 10-6 M NE 
were used. In some experiments, 20µg/ml of the purified antibody anti-mouse IL-10 
(eBioscience, San Diego, USA) were also added. Cells were collected 3 hours later for the 
analysis of gene expression by Real Time RT-PCR, whereas cell supernatants were collected 
6 hours later for the protein quantification by ELISA. 
 
Total RNA isolation and purification 
Mice skin was frozen in liquid nitrogen and then pulverized using a pre-chilled mortar and 
pestle. The powder was collected in Lysis/Binding Solution (RNAqueousTM Kit, Ambion Inc.) 
and homogenized by an electronic rotor-stator homogenizer (Polytron, Kinematica AG, 
Luzern, Switzerland). Alternatively, cells were collected in Lysis/Binding solution and 
homogenized by passing the lysate through a 25-gauge syringe needle. RNA extraction was 
performed following the kit instruction. Total RNA was further purified using the Turbo 
DNA-free kit (Ambion Inc.). The RNA concentration was quantified by ND-1000 
spectrophotometer (NanoDrop Technologies, Inc., Wilmington, USA). 
 
cDNA Synthesis 
0.5µg of total RNA from tissue samples or 1µg total RNA from cell samples, were reverse 
transcribed in a final volume of 100µl in the following reaction mixture: 5x First-Strand 
Buffer (Invitrogen, Carlsbad, USA), 10µM DTT (Invitrogen), 40 units RNase Inhibitor 
(Perkin Elmer, Waltham, USA), 500µM dNTP (Sigma), 300pM Random Hexamer pd(N)6 
(Pharmacia Biotech., Uppsala, Sweden), 400 units SuperScript II RT(Invitrogen). The tubes 
were incubated in the Peltier thermal cycler PTC-200 (MJ Research, Waltham, USA) at the 
following thermal conditions: 25°C for 10 minutes, 37°C for 60 minutes, 99°C for 5 minutes. 
An aliquot of each cDNA sample was used to perform a control PCR. 
 
PCR (polymerase chain reaction) 
5µl of cDNA was added to the following reaction mixture: 10X PCR Buffer II (Applied 
Biosystem, Foster City, USA), 3mM MgCl2 (Applied Biosystem), 320µM dNTP, 500nM 
primer forward and reverse, 1.25 units AmpliTaq Gold (Applied Biosystem) in a final volume 
of 50µl. The tubes were incubated in the Peltier thermal cycler PTC-200 at the following 
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conditions: 95°C for 10 minutes, 30 cycles: 93°C for 45 seconds, 55°C for 60 seconds, 72°C 
for 45 seconds and 72°C for 10 minutes. 
The primers used for the control PCR correspond to the HPRT housekeeping gene (Sigma) 
and their sequence is: Down: 5'-CGAGAGGTCCTTTTCACCAGC, Up: 5'-
GATTATGGACAGGACTGAAAG. 
 
Agarose gel electrophoresis 
Electrophoresis was performed on a horizontal gel at 1.8% agarose (peqGold Universal 
Agarose, PeqLab biotechnologies Gmbh, Erlangen, Switzerland) in TBE 0.5X buffer. 10µl of 
PCR products were loaded in the wells after addition of 2µl of loading buffer (0.25% 
bromophenol blue, 40% sucrose in water, PeqLab biotechnologies Gmbh). Electrophoresis 
was run for 5 minutes at 22V and for 60 minutes under a constant voltage of 100V. DNA 
fragments were visualized by staining the gel in an ethidium bromide solution for 10 minutes 
and by placing the gel on an ultraviolet transilluminator (Image Master VDS, Pharmacia 
Biotech). The size of the fragments obtained was evaluated by comparison to the 50bp DNA-
Leiter marker (PeqLab biotechnologies Gmbh). The size of the fragment obtained using the 
HPRT housekeeping gene primers was of 389bp. 
 
Semi-quantitative Real Time RT-PCR 
The PCR reaction was carried out using the SensiMix DNA kit (Quantance, London, UK) in a 
final volume of 25µl by adding 5µl of cDNA to the following reaction mixture: 2X SensiMix 
(dU), 4mM MgCl2, 0.5 Units UNG, 20X TaqMan probe (Applied Biosystems). Amplification 
of 18s rRNA was done for each sample as endogenous control of the amount and quality of 
total RNA added to each reaction. All samples were amplified in duplicate. The relative 
quantification of gene expression was done in the Rotor gene 2000 (Corbett Research, 
Sydney, Australia) by setting the thermal cycling conditions according to the manufacturer 
instructions and using the Rotor Gene Software to determine the threshold cycle (Ct value). 
The formula to determine the arbitrary units is 2-ΔΔCt, where ΔCt is the target gene Ct value 
minus the 18s Ct value and the ΔΔCt is the ΔCt of the treated sample minus the ΔCt of the 
control sample. Results are presented as the gene expression fold increase between treated 
samples and control. The arbitrary thresholds of 2-fold increase and 0.5-fold increase were 
chosen as biologically significant. 
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ELISA (enzyme linked immunosorbent assay) 
To quantitate protein production of IL-6, IL-10, IL-12, IL-17, IL-23 and IFN-γ in culture 
supernatant, the Ready-Set-Go! kit (eBioscience) was used. Briefly, a NUNC Maxisorp 96 
(NUNC, Roskilde, Danemark) wells ELISA plate was coated with capture antibody diluted 
1/250 in Coating buffer overnight at 4°C. The following day, the plate was washed 
extensively with Wash Buffer (PBS 1X, 0.05% Tween-20) and blocked with 1X Assay 
Diluent (eBioscience) for 1 hour at RT. Afterwards, appropriately diluted standards and 
samples were added to the plate and incubated for 2 hours at RT. Next, the Detection 
Antibody diluted 1/250 in 1x Assay Diluent was added to the wells for 1 hour at RT. The 
plate was then incubated with the Avidin-HRP enzyme diluted 1/250 in 1x Assay Diluent for 
30 minutes. Finally, the substrate solution was added to each well and after 15 minutes the 
reaction was stopped by adding 1M H3PO4. After each step, the plate was washed extensively 
with the Wash Solution. Optical density was determined at 450nm in MRX Microplate 
Reader (Dynex Technologies Inc., Chantilly, UK). 
 
Role of the lymphatic conduit system 
To study whether reagents injected intradermally could reach the draining lymph node by 
entering directly the lymphatic vessels, mice were injected i.d. with 9µg/mouse of PGN in 
presence or absence of 2.5µg/mouse of PRO in the pinna of the ear using an Hamilton syringe 
fitted with a 30.5 gauge needle. Control mice were injected with the same volume of PBS1X. 
Three hours later, 5µg/mouse of ovalbumin conjugated to Alexa Fluor 488 (OVA-Alexa 488, 
Invitrogen) was also injected in the same site. In some experiments the site of injection was 
surgically removed 5 hours after the pretreatment. To reduce the pain associated with the 
procedure, mice were given an intraperitoneal injection of a cocktail of xylazine 
(0.2mg/mouse, Rompun 2%, Bayer AG, Leverkusen, Germany) and ketamin (1.5mg/mouse, 
Ketalar, Pfizer, New York, USA) at the time of treatment and ear removal and the drinking 
water was supplemented with paracetamol (1.3mg/ml, Dafalgan, Bristol Myers SquibbCo., 
New York, USA). Twenty-four hours later the auricular draining lymph node was collected 
for single cell suspension preparation and FACS analysis. 
 
DCs adoptive transfer and Th cell polarization 
DCs, sorted as described above, were incubated at 106 cells/ml in a petri dish with a 
combination of the TLR-2 and the NOD2 agonists in presence of the soluble protein keyhole 
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limpet hemocyanin (KLH, Calbiochem) and in presence or absence of the β2-AR agonist 
salbutamol (Sigma). Notably, 10µg/ml PAM, 5µg/ml MDP, 100µg/ml KLH and 10-6 M 
salbutamol were used. After three hours cells were collected and mice were injected in the 
right hint footpad with 106 cells. To asses the adoptive response to KLH in terms of cytokine 
production, mice were sacrificed 7 days later and cells from the draining popliteal lymph 
nodes were obtained and incubated in complete medium at 5. 105cells/250µl/well in presence 
of 100µg/ml of KLH at 37°C for 48h. The culture supernatants were then collected and the 
concentration of IFN-γ and IL-17 were quantified by ELISA. 
 
Single cell suspension from lymph nodes 
Draining lymph nodes were collected in 1ml RPMI 1640 supplemented with 5% FCS and 
digested with 0.5mg/ml of Collagenase A (Roche Diagnostic) and 40µg/ml of DNase I 
(Roche Diagnostic) for 10 minutes at 37°C. Lymph nodes were then gently teased and cells 
were filtered through a 40µm cell strainer (BD Falcon, Bedford, USA). Cells were washed by 
spinning 10 minutes at 4°C with PBS1x supplemented with 5% FCS, 5mM EDTA and 
5µg/ml DNase I. The pellet was resuspended in PBS1x+ 1% FCS and cell number was 
counted using the Neubauer chamber (Paul Marienfeld Gmbh, Lauda-Königshofen, Germany) 
 
Flow cytometry (FACS) 
For all FACS analysis, 0.5. 106 cells were first incubated 5 minutes at 4°C with the purified 
antibody anti-mouse CD16/CD32 (BD Bioscience Pharmingen, San Jose, USA) to ensure 
blocking of Fc receptor. Afterwards, cells were labelled with phycoerythrine PE-conjugated 
anti CD11c antibody (BD Bioscience Pharmingen) or PE-conjugated m-PDCA-1 antibody 
mixture (Miltenyi Biotech) allowing a single color identification of CD11c+, CD45R+, 
B220+ and Ly-6C+, which identifie plasmacytoid dendritic cells (pDCs). The corresponding 
isotypes, PE conjugated Hamster IgG1, λ  and PE conjugated rat IgG2b, κ respectively, were 
used as negative control. 
 
Statistics 
Differences were analyzed by the Statview software and the repeated measures ANOVA test. 
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3.1 Introduction 
 
The skin is the largest organ of the body and plays a central role in host defense. The 
epidermis is composed of keratinocytes, which function both as physical barrier and early 
warning system. Immune cells of the epidermis include Langerhans cells and intraepithelial 
lymphocytes. The derma is composed of connective tissue produced by fibroblasts. Immune 
cells resident in the derma include dermal DCs, mast cells and cutaneous lymphocyte antigen-
positive memory T cells. Recently, we and others reported that catecholamines may affect 
skin Langerhans cells and bone marrow derived dendritic cells (DCs) migration and antigen 
presenting ability via adreneoceptors (ARs), (Maestroni, 2000; Maestroni, 2002a; Maestroni 
and Mazzola, 2003). However, these studies primarily investigated contact hypersensitivity 
responses using contact allergens. No in vivo evidence was available about a possible 
adrenergic modulation of innate or adaptive responses elicited by pattern recognition 
receptors (PRRs) that recognize specific microbial components (Takeda et al., 2003). Besides 
DCs and immune cells, epithelial cells, endothelial cells and fibroblasts express PRRs and are 
important players in cutaneous infections and inflammatory diseases (Faure et al., 2000; Kang 
et al., 2006; Sandor and Buc, 2005). Most cells that may react to PRR ligands, including 
Langerhans cells, DCs and epidermis keratinocytes express also β-ARs (Chen et al., 2002; 
Elenkov et al., 2000; Maestroni, 2006). The importance of PRRs (in particular of TLRs) and 
β-ARs have been both suggested to play a role in skin inflammation. However, a possible 
interplay between TLRs and β-ARs has not been investigated. As far as it concerns TLRs the 
evidence of their important role in skin disorders such as psoriasis and atopic dermatitis is 
steadily growing (Kang et al., 2006). The TLR-induced responses may be dependent or 
independent on the adaptor protein MyD88. Current opinion views MyD88 as essential for 
inflammatory cytokine production via all TLRs, whereas TRIF is involved in TLR3- and 
TLR4-mediated MyD88-independent induction of IFN-β (Takeda et al., 2003). In particular, 
the TLR2 pathway activated by PGN, (Dziarski and Gupta, 2005b) is MyD88-dependent and 
should lead to NFkB activation and production of inflammatory cytokines only, while that of 
TLR4 that sense LPS, should lead to the production of both inflammatory cytokines and IFN-
β (Takeda, 2005). 
For the β-adrenergic system, a dysregulation of catecholamine biosynthesis with epidermis 
norepinephrine levels associated with high numbers of β2-ARs in differentiating 
keratinocytes has been reported in vitiligo (Schallreuter, 1997). In atopic eczema, a point 
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mutation in the β2-AR gene could alter the structure and function of the receptor, thereby 
leading to a low density of receptors on both keratinocytes and peripheral blood lymphocytes 
(Schallreuter, 1997). In psoriasis, β-ARs are downregulated and, interestingly, β-AR blockers 
may cause psoriasiform, lichen planus-like, and eczematous "chronic" rashes (Halevy and 
Livni, 1993; Hodl, 1985; Steinkraus et al., 1993). Last but not least, the onset and course of 
dermatological disorders may be significantly influenced by stress, emotional disturbances, or 
psychiatric disorders (Chuh et al., 2006). 
Here we present evidence that β-ARs may affect the skin response to peptidoglycan (PGN) 
from S. Aureus but not to LPS from E. Coli. β−ARs inhibition and PGN injection before 
primary immunization with ovalbumin (OVA) dissolved in saline resulted in a Th1 shift of 
the recall memory response. This effect evidently depended on enhanced local expression of 
inflammatory cytokines as well as of IFN-β and CXCR3 ligands, which were associated with 
an increased number of pDCs in the draining lymph node. Both β1- and β2-ARs inhibition 
was apparently involved in the observed effects,   
 
3.2 Methods 
 
Mice 
BALB/c (H-2d) inbred mice were purchased from Harlan, Italy and transgenic DO11.10 (H-
2d) mice, expressing on 90% of CD4+ T cells a T cell receptor specific for the OVA peptide 
323-339, were a generous gift of Dr. Martin-Fontecha, Institute of Research in Biomedicine, 
Bellinzona, Switzerland. All the mice used in the experiments were female, 2-4 months old 
and were maintained in our animal room under a standard 12 h photoperiod, at 21 ± 1°C, with 
food and water ad libitum. All experiments were authorized by the local veterinary authority. 
 
Real time RT-PCR 
We measured the mRNA coding for TNF-α, IL-1α, IL-7, IL-12, IL-18, IL-23, IFN-γ, IL-10 
and the chemokines CCL-1, CCL-2, CCL5, CCL27. Groups of mice were injected 
intradermally (i.d.) with PGN or LPS ± the non-selective β-ARs antagonist propranolol 
(PRO). Total RNA isolated from skin samples was reverse transcribed using random 
hexamers and the TaqMan Reverse Transcription kit (Perkin-Elmer Applied Biosytems, 
Foster City, CA). A relative quantification of cytokine mRNA was done in a Rotor Gene 2000 
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(Corbett Research) using pre-developed reagents (Applied Biosystems, Foster City, CA, US). 
Amplification of 18S rRNA was done for each sample as endogenous control of the amount 
and quality of total RNA added to each reaction. Thermal cycling conditions were according 
to the manufacturer instructions. All samples were amplified in duplicate. Threshold cycle Ct, 
which correlates inversely with the target mRNA levels, was measured as the cycle number at 
which the reported fluorescence emission increased above a threshold level. The amount of 
inflammatory cytokine or IFN-β and CXCR3 ligands mRNA upon PGN or LPS injection was 
expressed as a n-fold difference relative to the amount of mRNA in controls injected with 
saline only. The formula used to determine this value is 2-∆∆Ct, where ∆Ct is determined by 
subtracting the average 18S rRNA value from the average target Ct value. The calculation of 
∆∆Ct involves the subtraction of the ∆Ct of control from the target ∆Ct value. 
 
Adoptive transfer and immunization  
Brachial, axillary, inguinal and popliteal lymph nodes were collected from DO11.10 mice. 
The lymph nodes were teased and the cells were filtered through a 40 µm cell strainer 
(Falcon) to prepare a single cell suspensions in RPMI 1640 with 5% FCS. Lymph node cell 
suspensions from DO11.10 mice contained 40 ± 1.5 % of cells expressing the OVA specific T 
cell receptor as assessed by flow cytometry using PE-conjugated anti- KJ1-26 mAb (Caltag 
Laboratories Invitrogen, Basel, Switzerland) The cells were then centrifuged, resuspended in 
PBS and 7.5 x 106 lymph node cells, containing 3 x10 6 transgenic KJ1-26+ cells, were 
injected i.v. into syngeneic BALB/c mice. 48 h later the mice were then injected intradermally 
(i.d.) in the shaved back with 100 µl of PBS containing 50 µg of S. Aureus peptidoglycan 
(PGN, Sigma, Co., St. Louis, USA) or 2 µg of E. Coli lipopolysaccharide (LPS, 0127:B8, 
Sigma) in presence or absence of propranolol (5 µg, Sigma) or ICI 118,551 (5 µg, Tocris 
Cookson Ltd, UK). After 3 h the mice were injected i.d. in the same site of the back with 100 
µl PBS containing 50 µg of ovalbumin (OVA, Sigma). Ten days later the mice were injected 
sc with 50 µg of OVA dissolved in 25 µl of PBS and emulsified in 25 µl of FCA. After 7 days 
the mice were challenged again sc with OVA to assess the DTH response and cytokine 
production in lymph node cell suspensions. 
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Cytokines in lymph node cells and delayed hypersensitivity (DTH) response 
Groups of mice were immunized as reported above and 17 days later (recall response) 
challenged with 50µg OVA in 50 µl PBS in the right hind footpad. The DTH response was 
assessed by measuring the degree of foot swelling of the OVA-injected foot compared with 
that of the vehicle–treated contralateral foot at 48 hours after challenge using a digital 
micrometer (Mitutoyo, Japan). To assess cytokine production, the mice were sacrificed 17 
days after immunization and the draining inguinal lymph node cells were obtained, seeded in 
microplates at 2 x 105 cells / 200 µl / well, and incubated in RPMI 1640, 10 % FCS at 37° C 
for 48 h in presence of 0, 10 and 100 µg/ml of OVA. Next, culture supernatants were 
collected and the concentration of IFN-γ and IL-4 were quantitated by ELISA (Becton 
Dickinson: Allschwill, Switzerland). 
 
In vivo migration 
Mice were injected id with PGN or LPS ± propranolol, ICI 118,551 or betaxolol (5µg, Tocris 
Cookson Ltd, UK) in the hind left footpad and 3 hours later with ovalbumin conjugated with 
Alexa Fluor 488 (5 µg /mouse, Invitrogen, Molecular Probes, Carlsbad, CA, USA) in the 
same site. In certain experiments PGN ± the combination of ICI 118,551 (5µg) and betaxolol 
(5µg) was also injected. 24 hours later the mice were killed and single-cell suspensions were 
prepared from the popliteal draining lymph nodes. Lymph nodes were incubated in 
Collagenase A, 0.5 mg/ml (Boehringer Mannheim, Rot Kreuz, Switzerland) and DNAse I (40 
µg/ml, Perkin Elmer, Rot Kreuz, Switzerland) for 10 min at 37° C. Afterwards the tissue was 
gently teased and cells were filtered through a 40 µm cell strainer (Falcon). Cells were 
washed and labelled with PE-conjugated anti-CD11c monoclonal antibody or with a PE-
conjugated mixture of monoclonal antibodies recognizing paces (Miltenyi Biotech) and 
analysed by flow cytometry to assess the percentage and number of CD11c+, Alexa Fluor 
488+ and pDCs, Alexa Fluor 488+ cells. Anti-mPDCA-1 antibodies from Miltenyi allow a 
single color identification of CD11c+, CD45R+ (B220+), Ly-6C+ pDCs. 
 
Statistics 
Differences were analyzed by one way analysis of variance with Dunnett’s test using the JMP 
software. 
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3.3 Results 
 
It has been known for many years that the decision of the T cell to mount a productive 
response (immunity) or to remain silent (tolerance) is controlled by the form in which the 
antigen is administered. Antigen with adjuvant leads to immunity, whereas soluble antigen 
without adjuvant leads to tolerance. Therefore we used PGN or LPS as adjuvant and studied 
whether the innate inflammatory response and the following adaptive responses to a soluble 
protein was under a sympathetic β-adrenergic control. 
 
Effect of β-ARs inhibition on the skin innate response upon PGN or LPS injection 
We investigated whether the pharmacological inhibition of the skin β-ARs coupled with 
activation of TLRs could influence inflammatory cytokines and chemokines gene expression 
in the skin. Three hours and six hours later the mice were sacrificed and the skin was excised 
at the site of injection for cytokine and chemokine gene expression analysis. We found that 
among the genes tested, both PGN and LPS enhanced the expression of TNF-α, IL-1α, IL-12, 
IL-23, IFN-γ, CCL2 and CCL5 especially at 3 hours after injection (data not shown). Figure 
9A shows that addition of PRO to PGN, but not to LPS, increased the skin expression of the 
IL-12, IL-23, and IFN-γ genes 3 hours after injection; the expression of IL-1α and CCL5 was 
around twofold and that of TNF-α and CCL2 was increased (data not shown) but did not 
reach the twofold increase chosen as arbitrary threshold to regard an effect as biologically 
relevant. The expression of the remaining genes was almost undetectable when compared to 
saline. Relative to LPS, PRO was able to induce only a weak increase of IFN-γ expression, an 
effect that was however much lower than that observed with PGN. Next we investigated 
whether the β2-AR specific antagonist ICI 118,551 could reproduce the effect of PRO on the 
PGN action. The effect was a slightly increased expression of IL-1α only (Fig. 9B). It should 
be noted that the cytokine gene expression induced by LPS was generally higher than that 
induced by PGN alone (data not shown). Only with the addition of PRO to PGN, the figures 
approached those of LPS. 
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Figure 9: Effect of β-ARs inhibition on cytokine and chemokine mRNA expression in the skin response to 
PGN or LPS. Mice were injected i.d. with PGN or LPS ± the non specific β-ARs antagonist propranolol (PRO) 
or with PGN ± the specific β2-ARs antagonist ICI 118,551. Panel A shows the fold increase in gene expression 
as evaluated 3 hours after treatment by real time RT-PCR. The bars are the mean ± SE of the ratios of the 
arbitrary units induced by injection of PGN or LPS in presence of the adrenergic antagonists divided by the 
arbitrary units induced by PGN or LPS alone obtained in 4 experiments (3 mice per group, 4 ratios). Panel B 
show the folds increase in the expression of the same genes 3 hours after injection of PGN in presence or 
absence of ICI 118,551. The mean of three experiments ± SE is shown. In all experiments, the arbitrary units 
were calculated taking as reference the gene expression after i.d. injection of saline. Twofold increase was taken 
as arbitrary threshold. 
 
We also verified if the lack of response in the LPS groups could depend on the dose by 
injecting a ten fold lower dose (0.2 µg LPS / mouse). We got a much lower cytokine response 
but even in this suboptimal situation, PRO failed to affect cytokine expression (data not 
shown). These results indicate that β1-ARs with a likely contribution of β2-ARs may 
influence the expression of IL-12, IL-23, and IFN-γ genes upon PGN but not LPS injection in 
the skin.  
 
Impact of β-ARs inhibition and PGN on the recall memory response to a soluble protein 
It is widely accepted that IL-12, IL-23 and IFN-γ are crucial for the development of Th1 
immune responses. Thus, we studied whether the boosting effect of β-ARs blockade in 
presence of PGN before primary immunization to OVA dissolved in PBS could influence the 
recall memory response. As a model we used BALB/c mice adoptively transferred with 
lymph node cells from transgenic DO11.10 mice containing 40% of CD4+ T cells expressing 
a T cell receptor specific for the OVA peptide 323-339. PGN in presence or absence of PRO 
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or ICI 118,551 was injected intradermally and 3 hours later, the mice were injected in the 
same skin site with OVA dissolved in saline. Ten days later the mice were boosted with OVA 
embedded in CFA. The delayed type hypersensitivity (DTH) response and cytokine 
production in the draining lymph nodes were assessed 7 days later. 
 
Figure 10: Effect of β-ARs inhibition and PGN injection before primary sensitization to OVA on the 
recall memory response. KJ1-26+ cells transferred mice were injected i.d. with PGN ± the non specific β-ARs 
antagonist PRO, 3 hours before immunization with OVA dissolved in saline. 17 days later the in vitro IFN-γ and 
IL-4 production in lymph node cells upon incubation with various concentrations of OVA (A) and the DTH 
response (B) were assessed. The curves in A represent the mean values ± the standard deviation per group (3 
experiments). The figures in brackets in B represent the number of mice tested per group. a: F( 1,28) = 6.40, p < 
0.02; b F (1, 40) = 4.47: p < 0.05; c: F ( 1, 18) = 6.64, p < 0.02 (ANOVA). 
 
Figure 10 shows that preconditioning the skin with PGN in presence of PRO resulted in a 
significantly stronger and Th1-shifted recall memory response as assessed by the pattern of 
cytokine production (Fig. 10A) and higher DTH response (Fig. 10B). When LPS was injected 
instead of PGN, the resulting adaptive response was of the Th1 type but PRO did not exert 
any influence on both cytokine production (Fig. 11A) and DTH response (Fig. 11B). Then, 
we investigated whether the specific β2-ARs antagonist ICI 118,551 could exert any effect 
when combined with PGN. The results reported in figure 12 show that ICI 118,551 did not 
affect the cytokine production (A) or the DTH response (B). These results were consistent 
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with the influence of PRO on the inflammatory response and suggest that the β1-ARs 
expressed in the skin participate in modulating the inflammatory response to PGN and 
influence the subsequent adaptive response to a soluble antigen. 
 
Figure 11: Effect of β-ARs inhibition and LPS injection before primary sensitization to OVA on the recall 
memory response. KJ1-26+ cells transferred mice were injected i.d. with LPS ± the non specific β-ARs 
antagonist PRO, 3 hours before immunization with OVA dissolved in saline. 17 days later the in vitro IFN-γ and 
IL-4 production in lymph node cells upon incubation with various concentrations of OVA (A) and the DTH 
response (B) were assessed. The curves in A represent the mean values ± the standard deviation of 12 mice per 
group (3 experiments). The figures in brackets in B represent the number of mice tested per group. 
 
Effect on skin DCs migration  
We wondered whether the amplified Th1 priming induced by the β-ARs blockade was due to 
an increased DCs migration and consequent antigen presentation. As cutaneous DCs include 
epidermal Langerhans cells, interstitial/dermal DCs as well as pDCs that, however, seems to 
appear in the skin mainly under pathological conditions (Valladeau and Saeland, 2005), we  
Michela Manni Institut de Biologie Université de Neuchâtel 
 57 
 
Figure 12: Effect of β2-ARs inhibition and PGN injection before primary sensitization to OVA on the 
recall memory response. KJ1-26+ cells transferred mice were injected i.d. with PGN ± the specific β2-ARs 
antagonist ICI 118,551 (ICI), 3 hours before immunization with OVA dissolved in saline. 17 days later the in 
vitro IFN-γ and IL-4 production in lymph node cells upon incubation with various concentrations of OVA (A) 
and the DTH response (B) were assessed. The curves in A and the bars in B represent the mean values ± the 
standard deviation of 12 mice per group (3 experiments). 
 
considered both myeloid and pDCs. Table 4 shows the lymph node cellularity and number of 
CD11c+, OVA+ (Alexa Fluor 488+) and pDCs, OVA+ in the popliteal draining lymph nodes 
24 hours after i.d. injection of PGN or LPS ± PRO or ICI 118,551 followed 3 hours later by 
OVA-Alexa Fluor 488 in the hind left footpad. The results indicate OVA+, pDCs were 
significantly increased in the mice whose skin was pre-conditioned by LPS before OVA-
Alexa Fluor 488 injection. No effect of PRO was however evident. In the PGN treated 
groups, the number of OVA+, pDCs was lower but the injection of PRO but not of ICI 
118,551 increased significantly their number. Hence, the increased Th1 priming induced by 
the PGN and β-ARs blockade might depend on a selective recruitment of pDCs, that in 
presence of a soluble antigen act as antigen presenting cells in the draining lymph node. 
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Table 4: In vivo migration of antigen-positive DC subset upon skin preconditioning 
 
 
Effect on IFN-β and CXCR3 ligands expression in the skin 
pDCs precursors may be recruited from the blood by CXCR3 ligands in the skin (Asselin-
Paturel et al., 2005; Kohrgruber et al., 2004). The question we asked was therefore whether 
IFN-β and the inducible chemokines CXCL9, CXCL10 were induced in the skin upon PGN + 
PRO treatment. We thus repeated the skin preconditioning and measured the IFN-β, CXCL9 
and CXCL10 gene expression in the skin 3 hours later. Fig. 13 shows that indeed the 
combination of PGN + PRO but not of LPS + PRO could induce an increase in the expression 
of these mediators in the skin 3 hours after preconditioning. It should be noted, however, that 
LPS per se could induce a higher expression of these genes. As the LPS induced a Th1 
memory response to soluble OVA (Fig. 11) was associated with high numbers of OVA+, 
pDCs in the draining lymph node (Table 4), the induction of IFN-β in the skin during the 
innate phase of the response is probably the critical event for recruitment of pDCs and for 
instruction of the consequent innate response to OVA. Therefore, we investigated the relative 
contribution of β1-ARs and β2-ARs in the IFN-β boosting following PGN injection in the 
skin by using the specific antagonists betaxolol (β1-AR) or ICI 118,551 (β2-ARs). Figure 14 
shows that neither betaxolol nor ICI 118,551 alone could augment the expression of IFN-β 
and of the CXCR3 ligands CXCL9, CXCL10 when injected together with PGN. 
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 PGN PGN+PRO LPS LPS+PRO 
IFN-beta 5.4+ 3.3 16.2+ 6.2 21.6+ 7 21.5+ 6.5 
CXCL-9 2.5+ 1.8 6.3+3.1 54.8+ 6.2 60.2+ 6.3 
CXCL-10 8.8+ 5.6 19.3+9.1 132.1+ 8.2 163.6+ 32.3 
 
Figure 13: Effect of β-ARs inhibition on IFN-β  and CXCR3 ligands mRNA expression in the skin 
response to PGN or LPS. Mice were injected i.d. with PGN or LPS ± PRO. The bars show the folds increase in 
gene expression as evaluated 3 hours after treatment by real time RT-PCR. The figures reported are the mean ± 
SE of the ratios of the arbitrary units induced by injection of PGN or LPS in presence of the β-ARs antagonists 
divided by the arbitrary units induced by PGN or LPS alone in 3 experiments (3 mice per group, 3 ratios). The 
table shows the mean of the arbitrary units ± SE in the various groups. In all experiments, the arbitrary units 
were calculated taking as reference the gene expression after i.d. injection of saline. Twofold increase was taken 
as arbitrary threshold. 
 
Figure 14: Effect of selective β1-ARs or β2-ARs inhibition on IFN-β  and CXCR3 ligands mRNA 
expression in the skin response to PGN. Mice were injected i.d. with PGN ± the specific β1-ARs antagonist 
betaxolol (BET) or the specific β2-ARs antagonist ICI 118, 551 (ICI). The bars show the folds increase in gene 
expression as evaluated 3 hours after treatment by real time RT-PCR. The figures reported are the mean ± SE of 
the ratios of the arbitrary units induced by injection of PGN in presence of the β-ARs antagonists divided by the 
arbitrary units induced by PGN alone in 3 experiments (3 mice per group, 3 ratios). 
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Effect of the combination of ICI 188,551 and betaxolol on pDCs recruitment 
The present results suggests that blockade of both β1-and β2-ARs enhanced recruitment 
and/or migration of pDCs that appears to be the crucial event linking the innate and adaptive 
immune response and producing the Th1 shift. In fact, the number of antigen positive pDCs in 
the draining lymph node was high in all groups in which the response to OVA was of the Th1 
type, that is, in the LPS ± PRO and PGN + PRO treated mice (Table 4). To further confirm 
that inhibition of both β-AR subtypes is needed to affect the response to PGN, we 
investigated whether the combination of ICI 118,551 and betaxolol could reproduce the effect 
of PRO. Table 5 shows the lymph node cellularity and number of CD11c+, OVA+ (Alexa 
Fluor 488+) and pDCs, OVA+ in the popliteal draining lymph nodes 24 hours after i.d. 
injection of PGN  ±  (ICI 118,551+ betaxolol) followed 3 hours later by OVA-Alexa Fluor 
488 in the hind left footpad. The data show that blockade of both β1-and β2-ARs by betaxolol 
and ICI 118,551 respectively resulted in a significant increase of pDCs in the draining lymph 
node just as it was the case with PRO (Table 4). However, at variance with PRO, the 
combination of the two specific antagonists produced also a significant increase of the general 
CD11c+, OVA+ DCs population. 
 
Table 5: In vivo migration of antigen-positive DC subset upon skin preconditioning with PGN+ (ICI 
118,551+betaxolol 
 
 
3.4 Discussion 
 
On the basis of the findings reported we suggest that inhibition of both β1- and β2−ARs is 
needed to heighten the inflammatory response to PGN but not to LPS in the skin. The 
adrenergic blockade affects the inflammatory cytokines IFN-γ, IL-12, IL-23 and IFN-β 
inducible chemokines. These chemokines are CXCR3 ligands that may attract CXCR3+ cells 
including pDCs (Kohrgruber et al., 2004). The increase of pDCs in the draining lymph node 
might depend on recruitment of specific precursors either in the skin followed by migration to 
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the lymph node or directly in the lymph node. In fact, interstitial fluid is constantly drained 
into lymph nodes via afferent lymph vessels. This conduit enables monocyte-derived 
macrophages and DCs to access lymph nodes from peripheral tissues. However, during 
inflammation in the skin, a second recruitment pathway is evoked that recruits large numbers 
of blood-borne cells to lymph nodes via high endothelial venules. In fact, inflamed peripheral 
tissues may project their local cytokine/ chemokine profile to high endothelial venules in 
draining lymph nodes and thereby exert "remote control" over the composition of leukocyte 
populations that home to these organs from the blood (Palframan et al., 2001). In any case, 
the combination of Th1 type inflammatory cytokines and pDCs recruitment lead to a Th1 –
type adaptive response to the foreign protein. This conclusion was also supported by the 
inability of ICI 118,551 to affect the adaptive response to OVA (Fig. 12) as well as IFN-β 
expression and pDCs number (Table 4). On the other hand, also the β1-ARs antagonist 
betaxolol failed to increase IFN-β expression (Fig.14) and the number of OVA+, pDCs in the 
draining lymph node when injected together with PGN (data not shown). On the contrary, the 
combination of ICI 118,551 with betaxolol reproduced the effect of PRO on the pDCs number 
(Table 5) confirming that both β1- and β2-ARs need to be inhibited to affect the response to 
PGN. In addition, the combination of the two specific antagonists led also to an increase of 
the general antigen positive CD11c+ cell population, an effect that was not observed with 
PRO (Table 4). This effect might depend on the dose (5 µg ICI 118,551 + 5 µg betaxolol in 
comparison with 5 µg of PRO) or on possible different pharmacological properties of the 
combination of the specific antagonists. 
The involvement of both β1- and β2-ARs might depend on a different cell source of the 
cytokines and chemokines implicated in the phenomenon or on the expression of both 
receptors on the target cell(s). Many cell types in the skin may express both β1- and β2-ARs: 
DCs (Maestroni, 2002b; Seiffert et al., 2002), macrophages (Sigola and Zinyama, 2000), 
fibroblasts (Yoshida et al., 1996), CD4+, CD25+ T cells (Maestroni, unpublished results) and, 
of course, endothelial cells. As all these cell types contribute in the inflammatory response 
with production of cytokines that may in turn exert a paracrine role on other cell types, it 
seems difficult to identify the primary target of both PGN and PRO without additional 
studies. In addition, β1- and β2-AR can form heterodimers and have altered pharmacological 
properties from the receptor homodimers (Lavoie and Hebert, 2003). In regard to the 
difference in the skin response to PGN and LPS, mast cells might play a role. In fact, it has 
been reported that activation of TLR2 and TLR4 by respective microligands in mast cells 
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produces a different cytokine response. Furthermore, TLR2- but not TLR4-dependent 
stimulation resulted in mast cell degranulation (Supajatura et al., 2002) This phenomenon 
might account for the different  innate and adaptive immune response elicited by PGN and 
LPS. In fact, the response to PGN alone was shifted toward the Th2 type while the response 
to LPS was clearly of the Th1 type as evidenced by the high IFN-γ/IL-4 ratio and by the 
strong DTH response (Fig.11). However, the involvement of mast cells cannot fully explain 
the different sensitivity to PRO and the need of inhibiting both β1- and β2-ARs. In fact, mast 
cell production of inflammatory mediators is regulated by β2-ARs only (Kay and Peachell, 
2005). Mast cells have been also described to exert an important role in the mobilization of 
Langerhans cells in response to PGN (Jawdat et al., 2006). In our case, the effect of β-ARs 
inhibition was mainly exerted on pDCs, a DCs subset that is not normally present in the skin. 
However, the different mast cell response to PGN and LPS might involve a different 
paracrine effect on other cell types bearing both β-AR subtypes. 
Perhaps, the reason for the different β2-ARs influence on the PGN and LPS response depends 
on signaling pathways involved. The scarce influence of the β2-ARs inhibition on the LPS 
response would suggest that β-ARs affect neither the MyD88-dependent nor –independent 
pathway. As a consequence, also the TLR2, Myd88-dependent, pathway should not be 
affected. Yet, in our hands the β-ARs blocking could equally enhance the inflammatory 
cytokine and IFN-β response upon PGN injection. PGN is a unique and essential component 
of the cell wall of virtually all bacteria, is not present in eukaryotes, and is an excellent target 
for the innate immune system. Indeed, unlike TLR4 that is the sole receptor for LPS (Palsson-
McDermott and O'Neill, 2004), there are numerous PGN recognition molecules that are 
distinct from TLR2. These include CD14, nucleotide oligomerization domain (Nod)-
containing proteins, a family of peptidoglycan recognition proteins, and PGN-lytic enzymes 
(Dziarski and Gupta, 2005a). Thus, it is possible that β-ARs have an effect on one or more of 
these latter PGN recognition molecules. This interpretation is also supported by the 
observation that activation of TLR2 alone does not lead to IFN-β production (Toshchakov et 
al., 2002). Nonetheless, a most recent report describes a so far unknown cross talk between 
the MyD88 and TRIF pathways originating by a TLR synergy (Ouyang et al., 2007). 
Accordingly, it is conceivable that the various PRRs stimulated by PGN, including TLR2, in 
presence of PRO realize a similar synergy resulting in a stimulation of IFN-β and related 
genes. 
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In previous studies we showed that β2-ARs in bone marrow derived DCs could affect the 
inflammatory cytokine response when the cells were activated in vitro with both PGN or LPS 
(Maestroni, 2002a). The apparent discrepancy of the present findings suggest that in the skin, 
the cell target of both PGN and LPS are dissimilar or react differently from bone marrow 
derived DCs. In any case, the present findings call attention to the role of the skin adrenergic 
system in our understanding of acquired inflammatory diseases. It is recognized that the 
sympathetic and parasympathetic nervous systems generally inhibit innate immune responses 
at systemic and regional levels, whereas the peripheral sensory nervous system tends to 
amplify local innate immune responses. These systems work together to first activate and 
amplify local inflammatory responses that contain or eliminate invading pathogens, and 
subsequently to terminate inflammation and restore host homeostasis (Sternberg, 2006).  
Thus, the physiological role of the skin adrenergic system might be that of limiting the Th1 
response to pathogens that are recognized by certain PRRs. This mechanism might have 
evolved to shape the appropriate immune response to bacteria or viruses that may hit the skin 
more frequently. Disorders of the adrenergic (β-ARs) regulation of the skin immune response 
may thus results in excessive or reduced Th1 priming and have pathological consequences. 
Such disorders may be secondary to emotional stress that has been reported to affect skin 
diseases such as atopic dermatitis and plaque psoriasis (Chuh et al., 2006). Pertinent to the 
present findings, excessive Th1-priming has been associated with an augmented risk for 
organ-specific autoimmune diseases (Kramer et al., 1996) and current pathogenesis concepts 
consider skin disorders such as psoriasis vulgaris, vitiligo and alopecia aerata as T cell 
mediated autoimmune diseases (Chow et al., 2005). What's more, pDCs in the skin were 
shown to play a critical pathogenetic role in psoriasis and atopic dermatitis (Nestle et al., 
2005; Novak and Bieber, 2005). IL-23 was reported to stimulate epidermis hyperplasia with 
implication for psoriasis pathogenesis (Chan et al., 2006). Likewise, skin colonization with S. 
Aureus has important implications in the pathogenesis of atopic dermatitis and psoriasis 
(Tomi et al., 2005). Thus, we might have disclosed part of the pathogenetic mechanisms of 
these skin disorders by linking the skin β-adrenergic system to selected PRR(s). Future 
studies should be aimed at identifying such PRR(s) and their possibly relevance in other 
immune-based skin disorders and in skin cancers. It is also conceivable that similar 
mechanisms might be at work in modulating mucosal immunity. Finally, our findings might 
find application in vaccines design. 
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IV. Additional results to β-adrenoceptor and relevance in 
inflammatory diseases 
 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 69 
4.1 TLR-2 and TLR-4 gene expression in murine skin 
 
In order to evaluate the expression of TLRs in murine skin cells, mice skin was incubated in 
dispase 5U/ml supplemented with 0.375% Trypsin for 1 hour at 37°C. Then, the dorsal part, 
corresponding to the epidermal sheets, was separated from the derma using sterile forceps. 
The gene expression of TLR-2 and TLR-4 in the whole skin, the epidermis and the derma was 
evaluated by Real time RT-PCR compared to the XS52 cell line. The results are expressed as 
the ratio of the arbitrary units of the derma or the whole skin compared to epidermis. 
 
 
 
 
 
 
 
 
 
Figure 15: TLRs distribution in mice skin. Mice skin was separated in epidermal sheets and derma and the 
mRNA expression of TLR-2 and TLR-4 was evaluated by Real time RT-PCR. The bars represent the ratio+SD 
of the arbitrary units of the derma or the whole skin compared to epidermis. In all experiments, the arbitrary 
units were calculated using the gene expression of the XS52 cell line as reference. 
 
The results presented in Fig. 15 show that TLR-2 and TLR-4 gene expression were 
respectively 23 and 158 times higher in the derma compared to the epidermis. In regard to the 
whole skin, the TLR-2 and TLR-4 mRNA expression was also increased compared to the 
epidermis 6 and 42 times respectively. This indicates that TLR-2 and TLR-4 are expressed 
ubiquitously in mice skin but predominantly in the dermal compartment. 
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4.2 Effect of PRO and ICI 118,551 on cytokine gene expression in murine skin 
 
We investigated whether the pharmacological inhibition of β-ARs per se may affect the gene 
expression of the proinflammatory cytokines IL-12, IFN-γ and IL-23 by real time RT-PCR in 
mice skin treated with 5µg of the specific β2-ARs antagonist ICI 118,551 or of the non-
specific β-ARs antagonist propranolol. 
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Figure 16: mRNA expression of the proinflammatory cytokines IL-12, IFN-γ  and IL-23. Mice were 
intradermally injected with 5µg of the specific β2-ARs antagonist ICI 118,551 or the non-specific β-ARs 
antagonist propranolol. 3 hours later, mice were sacrificed and the skin at the site of injection was collected for 
evaluation of the proinflammatory gene expression by Real time RT-PCR. The bars represent the arbitrary 
units+ SD calculated using the gene expression of mice treated with the vehicle alone as reference. 
 
Fig. 16 shows that injection of ICI 118,551 and PRO in mice skin had no significant influence 
on the gene expression of IL-12, IFN-γ and IL-23. There was no increase in arbitrary units in 
β-ARs antagonists treated mice compared to vehicle treated mice. We confirmed that 
pharmacological inhibition of β-ARs per se with the specific β2-ARs antagonist ICI 118,551 
or the non-specific β-ARs antagonist propranolol, had no effect on the mRNA expression of 
the proinflammatory cytokines IL-12, IFN-γ and IL-23. 
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4.3 Effects of β-ARs blockade on pDCs migration from ear 
 
Plasmacytoid DCs may be recruited into the draining lymph node directly from the blood via 
high endothelial venules56 or may enter the skin by CXCR3-chemotaxis and then migrate 
from the skin into the draining lymph node57,58. To test if the increased number of 
plasmacytoid DCs in the draining lymph node upon TLRs activation and OVA injection 
depended on a selective recruitment of these cells from the skin or directly from the blood, 
mice were injected i.d. with PGN in presence or absence of PRO in the ear pinna. Three hours 
later, OVA-Alexa 488, was injected in the same site and two hours later the ear was 
completely removed. Finally, after 24 hours the auricular draining lymph node was collected 
for single cell suspension preparation and FACS analysis. We reasoned that if pDCs in the 
draining lymph node had only a skin origin, we should not have found any increase in their 
number after the surgical removal of the ear. 
 
Table 6: In vivo migration of antigen positive DC subsets after ear skin preconditioning and surgical 
removal. 
Preconditioning n LN cells (x106) CD11c+, OVA+ (x103) pDCs, OVA+ (x103) 
PGN 10 11.5+ 4.1 65.5+ 22.7 39.7+ 24.4 
PGN+PRO 10 11.8+ 3.6 80.7+ 29.7 68.6+ 42.1 
PBS 5 4.9+ 1.7 41.8+ 15.4 5.4+ 4.2 
Mice were injected i.d. with PGN+ PRO in the ear pinna and three hours later with OVA-Alexa 488. Five hours 
after the preconditioning, the ear was completely removed. Twenty-four hours later, the mice were sacrificed and 
the auricular draining lymph node analyzed for lymph node cellularity and content of CD11c+,OVA+ cells and 
OVA+, pDCs. The table reports the mean + SD; n is the number of mice per group. 
 
The lymph node cellularity and the recruitment of CD11c+, OVA+ cells and OVA+, pDCs 
were significantly increased in mice preconditioned with PGN or PGN+PRO compared to 
control mice (Table 6). This suggests that PGN and OVA-Alexa 488 migrated from the 
injection site to the draining lymph node before the ear removal and influenced the 
recruitment of these cells from the blood. However, in contrast to the results of DCs migration 
reported in Table 4, the number of OVA+, pDCs was not significantly increased by addition 
of PRO in the preconditioning. This indicated that removal of the ear prevented the effect of 
PRO suggesting that pDCs may be recruited either from the blood or from the skin and that 
PRO affected especially the latter mechanism. 
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V. In vitro modulation of cytokines production by β-
adrenoceptors in pattern recognition receptor activated 
dendritic cells 
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5.1 In vitro modulation of cytokines production by NE in PRRs activated DCs 
 
In order to better characterize the observed modulation of the PGN signaling by β-ARs in 
vivo, we decided to investigate the effect of β-ARs on cytokine production in DCs activated in 
vitro with different PRRs. Unlike LPS, which is a specific TLR-4 ligand, PGN is recognized 
by different type of molecules, such as CD14, NOD receptors, PGN-lytic enzymes and PGN 
recognition proteins59. In particular, it has been reported that PGN from Gram positive and 
Gram negative bacteria may be internalized in cells and cleaved in subunits of MDP. Next, 
MDP may bind to the NOD2 receptor and activate the NFκB pathway and the transcription of 
inflammatory genes. Therefore, we investigated the influence of the β-ARs activation on the 
specific signaling pathway of the TLR-2 and NOD2 receptors. DCs were incubated either 
with PGN, the specific TLR-2 agonist PAM, the specific NOD2 agonist MDP and a 
combination of PAM and MDP in presence or absence of NE. Although it is well known that 
the physiological sympathetic neurotransmitter NE is not a specific agonist for β-ARs, 
previous studies showed that in DCs NE modulates cytokine production mainly by β-ARs54. 
Six hours later, the supernatants were collected for the determination of the pro- and anti-
inflammatory cytokines concentration by ELISA. 
 
5.1.1 NE effect on IL-12 production 
 
The production of the proinflammatory cytokine IL-12 was increased in DCs incubated with 
the TLR-2/NOD2 agonist PGN compared to control cells incubated with culture medium 
alone. Addition of the specific TLR-2 agonist PAM or the specific NOD2 agonist MDP to 
DCs had practically no effect on the production of IL-12, which remained under the detection 
threshold of the ELISA kit (15pg/ml) (Fig. 17). In contrast, when a combination of PAM and 
MDP was added, there was an appreciable increase in IL-12 production compared to control 
cells. However, this increase was considerably lower than that observed in DCs incubated 
with PGN. This difference may be explained by a possible difference in the receptor binding 
affinity of these different compounds to TLR-2 and NOD2 receptors as well as by the fact 
that PGN may be recognized by additional PRRs, as reported above. 
Addition of the NE to DCs incubated with PGN or with PAM+MDP dramatically reduced the 
production of IL-12, which in the case of PAM+MDP treatment decreased under the 
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minimum detection threshold. In contrast, addition of NE to DCs treated with either PAM, 
MDP or medium alone, had no effect on IL-12 production that still remained under the 
detection threshold. 
 
 
Figure 17: Effect of NE on IL-12 production in DCs incubated with PRRs agonists. 1.106/ml DCs were 
incubated either with 10µg/ml of PGN, 10µg/ml of PAM, 2 µg/ml MDP or a combination of 10µg/ml PAM+ 
2 µg/ml MDP in presence or absence of 10-6M NE. Six hours later, the supernatants were collected and IL-12 
concentration was determined by ELISA. The bars represent the mean of the cytokine production of 5 
independent experiments+SD. (ANOVA, *p<0.0001; **p<0.005). 
 
5.1.2 NE effect on IL-10 production 
 
 
Figure 18: Effect of NE on IL-10 production in DCs incubated with PRRs agonists. DCs were incubated 
either with 10µg/ml of PGN, 10µg/ml of PAM, 2 µg/ml MDP or a combination of 10µg/ml PAM+ 2 µg/ml 
MDP in presence or absence of 10-6M NE. Six hours later, the supernatants were collected and the IL-10 
concentration was determined by ELISA. The bars represent the mean of the cytokine production of 3 
independent experiments+SD. (*p<0.0001; **p<0.001). 
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In general, addition of either PGN, PAM, MDP or PAM+MDP to DCs cultures in vitro 
augmented the production of the anti-inflammatory cytokine IL-10 compared to control cells 
incubated with medium alone. PGN induced a greater production of IL-10 than PAM, MDP 
and PAM+MDP (Fig 18). As for the proinflammatory cytokine IL-12, this difference may be 
due to a lower binding affinity of PAM and MDP for the TLR-2 and NOD2 receptors 
compared to PGN as well as to the ability of PGN to bind to other PRRs. 
Addition of NE further increased the amount of IL-10 produced by DCs incubated with either 
PGN, the specific TLR-2 agonist PAM or the combination of PAM+MDP. Interestingly, all 
these compounds signal through TLR-2. In contrast, the IL-10 production resulting from 
NOD2 activation by MDP was not influenced by addition of NE in the culture medium. This 
suggested that the increased IL-10 production in DCs incubated with PGN in presence of NE, 
was due to a modulation of TLR-2 but not of NOD2 signaling. Addition of NE to control cells 
incubated with medium alone had no effect on IL-10 production. 
 
5.1.3 NE effect on IL-6 production 
 
 
Figure 19: Effect of NE on IL-6 production in DCs incubated with PRRs agonists. DCs were incubated 
either with 10µg/ml of PGN, 10µg/ml of PAM, 2 µg/ml MDP or a combination of 10µg/ml PAM+ 2 µg/ml 
MDP in presence or absence of 10-6M NE. Six hours later, the supernatants were collected and IL-6 
concentration was determined by ELISA. The bars represent the mean of the cytokine production of 5 
independent experiments+SD. (*p<0.001; **p<0.0001;*** p<0.005). 
 
DCs incubated with either PGN, PAM or the combination of PAM+MDP, increased the IL-6 
cytokine production compared to control cells incubated in medium alone. When DCs were 
* 
** 
*** 
Michela Manni Institut de Biologie Université de Neuchâtel 
 76 
incubated with the specific NOD2 receptor agonist MDP, there was also an increase in IL-6 
but to a much lower extent (Fig. 19). 
Addition of NE significantly increased the production of IL-6 in MDP treated DCs, while it 
had no effect on PAM and PAM+MDP treated cells. Moreover, as previously reported by 
other authors46, NE also significantly increased the production of IL-6 in control cells 
incubated in absence of proinflammatory stimuli. Surprisingly, in contrast to the MDP and 
PAM+MDP groups, addition of NE to DCs incubated with PGN, significantly decreased the 
amount of this cytokine in the culture supernatant compared to DCs incubated with PGN 
alone. This discrepancy might be explained by the ability of PGN to bind receptors different 
from TLR-2 and NOD2 and that might also induce transcription of proinflammatory cytokine 
genes. Moreover, it is known that IL-10 may inhibit the production of IL-6. Here, the 
increased IL-10 concentration in culture supernatants of DCs incubated with PGN, PAM and 
PAM+MDP in presence of NE may possibly affect the IL-6 production. 
 
5.1.4 NE effect on IL-23 production 
 
 
Figure 20: Effect of the addition of NE on IL-23 production in DCs incubated with PRRs agonists. DCs 
were incubated either with 10µg/ml of PGN, 10µg/ml of PAM, 2 µg/ml MDP or a combination of 10µg/ml 
PAM+ 2 µg/ml MDP in presence or absence of 10-6M NE. Six hours later, the supernatants were collected and 
IL-23 concentration was determined by ELISA. The bars represent the mean of the cytokine production of 3 
independent experiments+SD. (*p<0.0005). 
 
IL-23 production was increased in DCs incubated both with PGN or the combination of 
PAM+MDP compared to control cells. In contrast, PAM and MDP treated cells barely 
produced IL-23, which remained under the detection limit of the ELISA kit (30pg/ml). 
* 
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Addition of NE to DCs treated with PGN, significantly reduced the production of this 
cytokines, while it had no effect in all the other groups (Fig. 20). Again also for this cytokine 
a difference in the NE effect on PGN and PAM+MDP activated DCs was evident. The 
explanation might attain to the consideration quoted above for the other cytokines. 
 
5.1.5 NE effect on cytokines production in LPS stimulated DCs 
 
Although no effect of the β-ARs inhibition on the skin innate response to LPS was found in 
vivo (Fig. 9), we went back in vitro to test the effect of the addition of NE on cytokines 
production in DCs to investigate whether we could trace any difference between the PGN and 
LPS signaling. 
 
Figure 21: Effect of the addition of NE on cytokines production in DCs incubated with LPS. DCs were 
incubated with 1µg/ml of LPS, in presence or absence of 10-6M NE. Six hours later, the supernatants were 
collected and the cytokines concentration was determined by ELISA. The bars represent the mean of the 
cytokine production of 2 independent experiments+SD. (*p<0.0001, **p<0.01). 
 
As already reported in part in previous studies52,54 and in contrast with the in vivo 
experiments, addition of NE to DCs incubated with LPS significantly increased the 
production of the anti-inflammatory cytokine IL-10 while decreasing the production of IL-12, 
IL-6 and IL-23 (Fig. 21). The difference between the in vivo and in vitro experiments may 
probably be due to the presence in mice skin of many different cell types, such as mast cells 
and fibroblast, which may react to LPS+ βARs inhibition in a different way than DCs. 
Comparing DC cytokines modulation by NE upon PGN and LPS stimulation, we observed 
that LPS induced a significant (p<0.0001) greater production of IL-12 and IL-23 than PGN 
and that addition of NE to LPS treated DCs had a stronger effect on IL-6 and IL-23 (45% and 
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53% reduction respectively) than in PGN (27% and 39% reduction respectively) stimulated 
cells. 
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5.2 Effect of IL-10 neutralization on IL-6 and IL-23 production 
 
Previous studies have demonstrated that IL-10 may inhibit in a dose dependent manner the 
expression and the production of proinflammatory cytokines, notably of IL-6 in human 
monocytic cell line60, rat mast cells61 and murine microglial cell line62. Here, we wondered if 
the decrease in IL-6 production in PGN and NE treated cells could be explained by an IL-10 
inhibition of the NOD2-dependent IL-6 production. We demonstrated that addition of NE to 
PGN treated cells increased the production of IL-10 by affecting the TLR-2 signaling 
pathway (Fig. 18). Possibly, this augmented production of IL-10 inhibited the production of 
IL-6 by the NOD2 pathway resulting in a decreased IL-6 concentration in the supernatant of 
PGN+NE treated DCs compared to PGN alone. Furthermore, we wondered if this effect 
might also influence the IL-23 production. Therefore, DCs were incubated in vitro either with 
PGN, the specific TLR-2 agonist PAM and the combination of PAM+MDP in presence or 
absence of NE and of the purified antibody anti-mouse IL-10. Six hours later, the 
supernatants were collected for determination of the IL-6 and IL-23 concentration by ELISA. 
 
5.2.1 Effect of IL-10 neutralization on IL-6 and IL-23 production upon PGN+ NE treatment 
of DCs 
 
                
Figure 22: Effect of IL-10 neutralization on IL-6 and IL-23 production in DCs incubated with PGN+NE. 
DCs were incubated with 10µg/ml of PGN in presence or absence of 10-6M NE. In some experiments 20µg/ml 
of the purified antibody anti-mouse IL-10 was also added. Six hours later, the supernatants were collected and 
IL-6 and IL-23 concentration determined by ELISA. The bars represent the mean of the cytokine production of 3 
independent experiments+SD. (*p<0.0001). 
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Addition of the anti-mouse IL-10 antibody to DCs treated with PGN or PGN+NE apparently 
abolished the production of IL-10 confirming the neutralization ability of the antibody (data 
not shown). Furthermore, production of IL-6 and IL-23 in these cells was significantly 
increased compared to DCs treated with PGN or PGN+NE. However, no difference was 
detected between DCs incubated with PGN+Ab IL-10 and PGN+NE+Ab IL-10 (Fig. 22). 
This indicated that the increased production of IL-10 in DCs treated with PGN and NE was 
responsible for the decreased production of IL-6 and IL-23.  
 
5.2.2 Effect of IL-10 neutralization on IL-6 and IL-23 production upon PAM+ NE treatment 
of DCs 
 
           
Figure 23: Effect of IL-10 neutralization on IL-6 and IL-23 production in DCs incubated with PAM+NE. 
DCs were incubated with 10µg/ml of PAM in presence or absence of 10-6M NE. In some experiments 20µg/ml 
of the purified antibody anti-mouse IL-10 was also added. Six hours later, the supernatants were collected and 
the IL-6 and IL-23 concentration determined by ELISA. The bars represent the mean of the cytokine production 
of 2 independent experiments+SD (* p<0.01). 
 
In contrast with the results obtained in DCs incubated with PGN+NE, addition of the antibody 
to DCs stimulated by PAM in presence or absence of NE had no effect on IL-6 production 
(Fig. 23). This suggested that IL-10 may inhibit IL-6 production triggered by NOD2 but not 
by TLR2. On the contrary, neutralization of IL-10 significantly increased the production of 
IL-23 in DCs stimulated with PAM in presence or absence of NE. However, there were no 
significant difference between DCs stimulated with PAM+Ab IL-10 and PAM+NE+Ab IL-
10. In conclusion, TLR-2 dependent IL-23 production might be modulated by IL-10. 
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5.2.3 Effect of IL-10 neutralization on IL-6 and IL-23 production upon PAM+MDP+ NE 
treatment of DCs 
 
                   
Figure 24: Effect of IL-10 neutralization on IL-6 and IL-23 production in DCs incubated with 
PAM+MDP+NE. DCs were incubated with 10µg/ml of PAM+2µg/ml of MDP in presence or absence of 10-6M 
NE. In some experiments 20µg/ml of the purified antibody anti-mouse IL-10 was also added. Six hours later, the 
supernatants were collected and the IL-6 and IL-23 concentration was determined by ELISA. The bars represent 
the mean of the cytokine production of 2 independent experiments+SD. (*p<0.05; **p<0.0001). 
 
The anti-mouse IL-10 antibody increased IL-6 production in PAM+MDP stimulated DCs in 
presence but not in absence of NE (Fig. 24). This may be due to the existence of a minimum 
concentration that IL-10 has to reach to be able to inhibit IL-6. In fact, the concentration of 
IL-10 was considerably higher in PAM+MDP+NE stimulated DCs than in those activated by 
PAM+MDP alone (Fig. 18). Consequently, addition of the anti-mouse IL-10 antibody had an 
effect only on DCs in presence of NE. This consideration is supported also by the observation 
that the anti-mouse IL-10 antibody was effective in increasing IL-6 in PGN and PGN+NE 
treated DCs. In fact, in both these groups the concentration of IL-10 was higher than that 
found in supernatant from DCs stimulated with PAM+MDP alone. Moreover, the TLR-
2/NOD2 agonists ratio used in the experiment might be different from the ratio in PGN 
probably in favor of NOD2. 
Concerning IL-23 production, neutralization of IL-10 significantly increased the 
concentration in PAM+MDP stimulated DCs in presence or absence of NE. 
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5.3 In vitro modulation of cytokine mRNA expression by NE in PRRs activated DCs 
 
In order to test if the in vitro modulation of the DC cytokines production by NE upon PRRs 
activation was exerted at the level of mRNA expression, DCs were incubated either with 
PGN, PAM, MDP, PAM+MDP or LPS in presence or absence of NE. Three hours later, cells 
were collected, the total RNA extracted and the cytokines gene expression analyzed by real 
time RT-PCR. 
 
5.3.1 NE effect on cytokines mRNA expression in PGN stimulated DCs 
 
 
Figure 25: Effect of NE on cytokines mRNA expression in DCs incubated with PGN. DCs were incubated 
with 10µg/ml of PGN in presence or absence of 10-6M NE. Three hours later, the cells were collected and the 
cytokines mRNA expression evaluated by Real Time RT-PCR. The bars represent the ratio+SD of the arbitrary 
units of PGN+NE treated cells over that of PGN treated cells as obtained in 3 independent experiments. In all 
experiments, the arbitrary units were calculated using the gene expression of DCs incubated with culture 
medium alone as reference. Twofold increase and 0.5 fold increase were taken as arbitrary threshold for 
biological significance. 
 
In agreement with the results obtained for protein production, IL-12 and IL-10 mRNA 
expression was respectively decreased and increased in DCs stimulated with PGN+NE 
compared to DCs stimulated with PGN alone. On the contrary, there was no difference 
between IL-6 and IL-23 mRNA expression in the two groups (Fig. 25), while, at the protein 
level, these two cytokines were both significantly decreased (Fig. 19 and 20). 
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5.3.2 NE effect on cytokines mRNA expression in PAM stimulated DCs 
 
 
Figure 26: Effect of NE on cytokines mRNA expression in DCs incubated with PAM. DCs were incubated 
with 10µg/ml of PAM in presence or absence of 10-6M NE. Three hours later, the cells were collected and the 
cytokines mRNA expression evaluated by Real Time RT-PCR. The bars represent the ratio+SD of the arbitrary 
units of PAM+NE treated cells over that of PAM treated cells of 5 independent experiments. In all experiments, 
the arbitrary units were calculated using the gene expression of DCs incubated with culture medium alone as 
reference. Twofold increase and 0.5 fold increase were taken as arbitrary threshold for biological significance. 
 
The IL-10 mRNA expression was increased in DCs treated with PAM+NE compared to DCs 
treated with PAM alone (Fig. 26). This is in agreement with the effect on the IL-10 protein 
concentration in culture supernatants. Furthermore, there was no difference in gene 
expression of IL-12, IL-6 and IL-23 in the two groups. In accordance, IL-6 was not modulated 
by NE at the protein level. As far as it concerns IL-12 and IL-23, the protein concentration in 
the DC supernatants were under the lower detection threshold of the ELISA kit (Fig. 17, 19 
and 20), indicating that these cytokines were not activated. 
 
 
 
 
 
 
 
 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 84 
5.3.3 NE effect on cytokines mRNA expression in MDP stimulated DCs 
 
 
Figure 27: Effect of NE on cytokines mRNA expression in DCs incubated with MDP. DCs were incubated 
with 2µg/ml of MDP in presence or absence of 10-6M NE. Three hours later, the cells were collected and the 
cytokines mRNA expression evaluated by Real Time RT-PCR. The bars represent the ratio+SD of the arbitrary 
units of MDP+NE treated cells over that of MDP treated cells obtained in 3 independent experiments. In all 
experiments, the arbitrary units were calculated using the gene expression of DCs incubated with the culture 
medium alone as reference. Twofold increase and 0.5 fold increase were taken as arbitrary thresholds for 
biological significance. 
 
Consistently with the results obtained for IL-6 concentration in DC supernatants, IL-6 gene 
expression in DCs stimulated with MDP+NE was also increased compared to DCs stimulated 
with MDP alone. No difference in IL-12 and IL-23 gene expression was apparent between the 
two groups (Fig. 27). However, the production of these two cytokines in the culture 
supernatant was under the detection limit of the ELISA kit (Fig. 17 and 20). In contrast with 
the protein result, the IL-10 mRNA expression was increased in DCs incubated with 
MDP+NE compared to DCs incubated with MDP alone. This may be explained by the very 
low level of IL-10 gene expression induced by MDP in DCs (Table 7). In contrast with PAM 
stimulated DCs, where there was an effective increase in IL-10 mRNA and protein, the 
arbitrary units for the IL-10 gene expression in MDP treated DCs were not increased 
compared to control cells incubated with medium alone. Although the addition of NE may 
increment the arbitrary units of MDP treated cells, this increment was probably not sufficient 
for an effective increase of the IL-10 production at the protein level. 
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Table 7: NE effect on IL-10 mRNA expression in MDP and PAM stimulated DCs 
DCs were incubated with 2µg/ml of MDP or 10µg/ml of PAM in presence or absence of 10-6M NE. Three hours 
later, the cells were collected and the cytokines mRNA expression evaluated by Real Time RT-PCR. The table 
report the arbitrary units of three independent experiments. In all experiments, the arbitrary units were calculated 
using the gene expression of DCs incubated with the culture medium alone as reference (AU=1). AU: Arbitrary 
Units. 
 
It has been reported that NE affect DCs mainly through β-ARs54. However, no evidence of a 
β-ARs modulation of the NOD2 signaling pathway has been reported. To investigate if NE 
increased IL-6 gene expression through a β2-ARs-dependent modulation of NOD2 signaling, 
DCs obtained from β2-AR gene deficient mice were incubated in vitro with MDP in presence 
or absence of NE. Three hours later, cells were collected for determination of the IL-6 gene 
expression by Real Time RT-PCR. 
 
 
Figure 28: Effect of NE on IL-6 gene expression in wt and β2ko derived DCs stimulated with MDP. Wt or 
β2ko derived DCs were incubated with 2µg/ml of MDP in presence or absence of 10-6M NE. Three hours later, 
cells were collected and the cytokines mRNA expression evaluated by Real Time RT-PCR. The bars represent 
the ratio+SD of the arbitrary units of MDP+NE treated cells over that of MDP treated cells obtained in 3 
independent experiments. In all experiments, the arbitrary units were calculated using the gene expression of 
DCs incubated with the culture medium alone as reference. Twofold increase and 0.5 fold increase were taken as 
arbitrary thresholds for biological significance. 
 
MDP (AU) MDP+NE (AU) PAM (AU) PAM+NE (AU) Medium (AU) 
1.60 6.63 46.52 233.94 1 
1.59 9.09 43.26 148.57 1 
2.64 20.11 21.70 183.54 1 
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As expected, in contrast with wild type mice, where the addition of NE augmented the IL-6 
gene expression, in β2ko derived DCs addition of NE to MDP treatment had no effect on the 
IL-6 gene expression (Fig. 28). This demonstrates that, as for others PRRs, NE modulated the 
NOD2 signaling in DCs by β2-ARs. 
 
5.3.4 NE effect on cytokines mRNA expression in PAM+MDP stimulated DCs 
 
 
Figure 29: Effect of NE on cytokines mRNA expression in DCs incubated with PAM+MDP. DCs were 
incubated with 10µg/ml of PAM+ 2µg/ml of MDP in presence or absence of 10-6M NE. Three hours later, the 
cells were collected and the cytokines mRNA expression evaluated by Real Time RT-PCR. The bars represent 
the ratio+SD of the arbitrary units of PAM+MDP+NE treated cells over that of PAM+MDP treated cells 
obtained in 3 independent experiments. In all experiments the arbitrary units were calculated using the gene 
expression of DCs incubated with the culture medium alone as reference. Twofold increase and 0.5 fold increase 
were taken as arbitrary thresholds for biological significance. 
 
As in protein studies, IL-10 gene expression was increased in DCs incubated with 
PAM+MDP in presence of NE compared to DCs incubated with PAM+MDP alone (Fig. 29). 
No difference in gene expression was detected for IL-12, IL-6 and IL-23. These results are 
consonant with the protein determinations for IL-6 and IL-23 but not for IL-12. The absence 
of a IL-12 mRNA modulation by NE may be explained by the low level of IL-12 protein 
production in PAM+MDP+NE stimulated DCs (Fig. 17). The protein concentration is next to 
the detection threshold of the ELISA kit, so that the decreasing trend observed at the gene 
expression level for PAM+MDP treated DCs in presence of NE might be sufficient for a 
significant protein decrease. 
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5.3.5 NE effect on cytokines mRNA expression in LPS stimulated DCs 
 
 
Figure 30: Effect of NE on cytokines mRNA expression in DCs incubated with LPS. DCs were incubated 
with 1µg/ml of LPS in presence or absence of 10-6M NE. Three hours later, the cells were collected and the 
cytokines mRNA expression evaluated by Real Time RT-PCR. The bars represent the ratio+SD of the arbitrary 
units of LPS+NE treated cells over that of LPS treated cells obtained in 3 independent experiments. In all 
experiments the arbitrary units were calculated using the gene expression of DCs incubated with the culture 
medium alone as reference. Twofold increase and 0.5 fold increase were taken as arbitrary threshold for 
biological significance. 
 
In agreement with our previous results, IL-12 and IL-10 gene expression were respectively 
decreased and increased in LPS+NE stimulated DCs compared to LPS treated DCs. However, 
in contrast with the results obtained for the protein concentration in DCs supernatant, no 
difference in gene expression was detected for IL-6 and IL-23 cytokines (Fig. 30). 
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5.4 Impact of β2-ARs activation in TLR-2 and NOD2 stimulated DCs on the adaptive 
response to a soluble protein upon adoptive transfer in vivo 
 
It is widely accepted that IL-12 is crucial for the development of Th1 immune response while 
IL-6 and IL-23 are involved in the Th17 development24. To test if β2-ARs activation in TLR-
2 and NOD2 stimulated DCs may influence the adaptive response to a soluble protein, DCs 
were incubated with PAM+MDP in presence of the soluble protein KLH and in presence or 
absence of the β2-AR agonist salbutamol. Three hours later, DCs were injected i.d. in the 
mice hint footpad and seven days later the IFN-γ and IL-17 production was assessed by 
ELISA in draining lymph node cells upon in vitro restimulation with KLH. 
 
 
Figure 31: Effect of β2-ARs activation in TLR-2 and NOD2 stimulated DCs on the adoptive response to a 
soluble protein. DCs were incubated with 10µg/ml PAM+ 5µg/ml MDP+ 100µg/ml of the soluble protein KLH 
in presence or absence of 10-6M of the β2-ARs agonist salbutamol. Three hours later, DCs were washed and 
injected in mice hint footpad and 7 days later the in vitro IL-17 and IFN-γ production in lymph node cells 
reincubated with 100µg/ml KLH was assessed by ELISA. The bars represent the mean of the cytokine 
production of 3 mice +SD. (*p<0.05, **p<0.0001). 
 
Consistently with our in vitro results, showing that addition of NE inhibited the production of 
the proinflammatory cytokine IL-12 but not that of IL-6 and IL-23 in DCs stimulated with 
PAM+MDP, here we found that PAM+MDP stimulation of DCs induced a Th17 response to 
the protein. Activation of β2-ARs in these DCs did reduce the Th1 priming but not the Th17 
priming as assessed by the strong reduction of IFN-γ and the weak albeit significant effect on 
IL-17 production (Fig. 31). The ratio of IFN-γ over IL-17 was consequently strongly 
** 
* 
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decreased in mice injected with DCs preconditioned with sabutamol (1.69) compared to mice 
injected with DCs preincubated with PAM+MDP+KLH (2.8). 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 90 
 
 
 
 
 
 
 
 
 
VI. Effects of the salivary gland extract (EGS) from Ixodes 
ricinus on pDCs migration 
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Mice were injected i.d. in the pinna of the ear using an Hamilton syringe fitted with a 30.5 
gauge needle with 5µg/mouse of PGN in presence or absence of 2µl/mouse EGS (generous 
gift of Prof. M. Brossard, University of Neuchâtel, Switzerland). Control mice were injected 
with EGS alone or with PBS 1X. Twenty-four hours later the auricular draining lymph node 
was collected for single cell suspension preparation and FACS analysis. Cells were labelled 
either with the PE-conjugated-m-PDCA-1 antibody, identifying pDCs, or with the PE-
conjugated-CD8a antibody and the FITC-conjugated-CD11c antibody, identifying lymphoid 
DCs. 
 
Table 8: In vivo migration of antigen-positive pDC subset upon skin preconditioning 
Preconditioning n LN cells (x106) CD8a+,CD11c+ (x103) pDCs (x103) 
PGN 8 9.4+ 2.2 46.6+ 14.2 67.4+ 18.0 
PGN+EGS 9 11.7+ 2.6 59.7+ 13.1 96.9+ 27.5 a 
EGS 6 5.8+ 1.2 35.9+ 10.7 46.9+ 13.8 
PBS 6 5.3+ 0.9 34.6+ 9.8 49.9+ 10.6 
The figure report the mean+ the standard deviation; n is the number of mice per group. a: p<0.05. 
 
Treatment of mice skin with PGN increased the migration of pDCs and CD8a+,CD11c+ cells 
into the auricular draining lymph node compared to control mice injected with EGS or PBS 
alone. However, addition of the salivary gland extract to the treatment significantly increased 
the number of pDCs, but not that of CD8+,CD11c+ cells. These results suggested, as our 
previous results showed in Table 4 and 6, that PGN and EGS exerts their effects either at 
local level, by influencing pDCs migration from the site of inflammation to the node, or at the 
draining lymph node level. In fact, the local induced cytokine/chemokines and PGN and EGS 
themselves might migrate from the site of injection through the lymphatic vessels into the 
node. There, they might influence the recruitment of pDCs from the blood into the node by 
inducing the expression of CXCR3 ligands and adhesion molecules on the high endothelial 
venules. This would also indicate that EGS might contain either some PAMPs or chemokines 
that would mediate the effect observed. 
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VII. Discussion 
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In our previous studies we demonstrated the existence of a β-ARs modulation of the skin 
innate and adaptive immune response; β-ARs blockade in mice skin enhanced the 
inflammatory cytokine and the IFN-β inducible chemokine gene expression in response to 
PGN but not to LPS. This had also an influence on the DTH response and on the cytokine 
production in the draining lymph node that switched towards the Th1 type. Moreover, the 
recruitment of pDCs into the draining lymph node was also increased. The use of a mixture of 
PGN and EGS also increased the pDCs migration compared to PGN alone (Table 8). This 
result suggested that EGS might contain either some PAMPs or chemokines that would act in 
synergy with PGN to influence the pDCs migration. These cells may be recruited to the 
draining lymph node either directly from the blood via the high endothelial venules or from 
the blood in the skin followed by migration in the lymph node. 
We found that removal of the ear after skin preconditioning with PGN+PRO followed by 
OVA-Alexa 488 injection had no influence on the lymph node cellularity and on the 
recruitment of CD11c+, OVA+ cells and OVA+, pDCs, which were significantly increased 
compared to control mice injected with saline (Table 6). This suggests that preconditioning of 
the ear exerts a fast and direct influence on the draining lymph node possibly by direct PGN 
and OVA-Alexa 488 migration from the site of injection before ear removal or by projection 
of the local induced inflammatory cytokines/chemokines profile to the draining lymph node. 
Both mechanisms have been indeed described, exogenous substances injected in the skin and/ 
or skin-generated cytokines or chemokines may directly reach the lymph node through the 
lymphatic conduit system63. Once in the node, PGN, cytokines and chemokines may affect 
the recruitment of blood cells and consequently change the lymph node cell composition. 
Addition of PRO in the preconditioning before ear removal had no significant effect on 
recruitment of pDCs in contrast with the results obtained in intact mice (Table 6). This 
indicates that removal of the ear prevented the effect of PRO suggesting that pDCs may be 
recruited either from the blood or from the ear skin and that PRO affect especially the latter 
mechanism. 
Taken together our in vivo findings show that NE exerts anti-inflammatory effects on the 
PGN induced cytokines production in DCs and confirm our previous results obtained in vivo 
and, in part, in vitro54. Here, the adrenergic activation along with PGN stimulation decreased 
the production of the inflammatory cytokines IL-12, IL-6 and IL-23 and increased that of IL-
10. However, PGN is sensed not only by TLR-2 but also by other different PRRs, including 
Michela Manni Institut de Biologie Université de Neuchâtel 
 94 
the NOD2 receptor. Hence, using specific agonists for the TLR-2 and NOD2 receptors, we 
analyzed more in detail the NE modulation of the TLR-2 and NOD2 signaling pathway. 
First of all, we confirmed that NE reduced IL-12 production in PGN treated DCs. In contrast, 
PAM or MDP stimulated DCs in presence or absence of NE practically did not produce IL-
12. However, when a combination of PAM+MDP was used, there was an increased 
production of IL-12, which was just over the minimum detection threshold of the ELISA kit 
and was abolished by the addition of NE (Fig. 17). This suggested that both TLR-2 and 
NOD2 receptors were implicated in the PGN induced IL-12 production and that their agonists 
may operate synergistically. However, the IL-12 production observed in PAM+MDP+NE 
groups was considerably lower than in PGN+NE groups. This difference might be explained 
by a different receptor binding affinity of these compounds for TLR-2 and NOD2 receptors as 
well as by the ability of PGN to bind additional PRRs other than TLR-2 and NOD2. These 
results were further confirmed by the IL-12 gene expression in PGN+NE, PAM+NE and 
MDP+NE treated DCs. In PAM+MDP+NE, there was a decrease in IL-12 mRNA expression 
that, however, did not reach the arbitrary threshold for biological significance (0.5). The 
contrasting NE effect observed at the protein level might depend on the low concentration, 
next to the detection threshold, of IL-12 found in the culture supernatant. Possibly, the slight 
decrease observed at the gene expression level for PAM+MDP treated DCs in presence of NE 
was sufficient to induce a significant decrease of the protein concentration. Nevertheless, one 
should consider that values obtained under the detection threshold were not reliable. 
Next, we demonstrated that the TLR-2, but not the NOD2, component of the PGN signaling is 
responsible for the increased IL-10 production induced by NE. In fact, NE was unable to 
enhance IL-10 production in MDP treated cells, while it strongly increased IL-10 production 
in PGN, PAM and PAM+MDP stimulated DCs (Fig. 18). These results were also confirmed 
by the cytokine gene expression analysis. NE amplified the IL-10 mRNA expression in DCs 
treated with PGN, PAM and PAM+MDP, indicating that NE may act on IL-10 production by 
modulating its gene expression. Contrary to what we expected on the basis of the protein 
results, NE also increased the IL-10 mRNA expression in MDP stimulated DCs. This 
apparent discrepancy might depend on the very low induction of IL-10 gene expression in 
MDP treated DCs. In fact, although NE augmented the IL-10 gene expression in MDP treated 
cells, the increment was minimal and probably not sufficient for an effective increase of the 
IL-10 production at the protein level. As a matter of facts, the arbitrary units relative to the 
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IL-10 gene expression in MDP+NE treated DCs were much lower than those induced by all 
other treatments in absence of NE (Table 7). 
Afterwards, we demonstrated that NE might modulate the NOD2 signaling pathway affecting 
the production of IL-6. Indeed, MDP stimulated DCs significantly increased the IL-6 
production in presence of NE. On the contrary, no influence of NE on PAM induced IL-6 
production was found (Fig 19). This provided evidence of a NE dependent modulation of IL-6 
production through NOD2 but not TLR-2 signaling pathway. These results were also 
confirmed by the increased IL-6 gene expression induced in MDP, but not in PAM, treated 
cells in presence of NE. This suggests that, as found for IL-10, NE may influence the NOD2-
dependent IL-6 production by modulating its gene expression. 
Although it has been reported that NE affect DCs mainly through β-ARs52, until now, no 
evidence of a β-ARs modulation of the NOD2 signaling pathway was demonstrated. 
Therefore, we investigated if the increased IL-6 gene expression in MDP treated DCs in 
presence of NE was mediated by β2-ARs using DCs derived from β2ko mice. In effect, no 
difference in IL-6 gene expression was detected in DCs treated with MDP in presence or 
absence of NE. This result provided evidence of the involvement of β2-ARs in the NE 
modulation of the NOD2 mediated IL-6 production. 
Surprisingly, in PGN stimulated DCs, NE exerted an inhibitory effect also on the production 
of IL-6. We hypothesized that this unexpected result could depend on the NE and TLR-2 
induced increase of IL-10. In fact, it has been demonstrated that IL-10 may inhibit in a dose 
dependent manner the expression and production of IL-660,61,62. Therefore, we wondered if the 
decreased IL-6 production in PGN+NE treated cells could be explained by an IL-10 inhibition 
of the NOD2-dependent IL-6 production. As previously reported, the IL-10 concentration in 
the supernatant of PGN+NE, but not of MDP+NE, treated cells was increased compared to 
DCs treated with the PAMPs alone. Possibly, this increment affected the IL-6 production by 
the NOD2 pathway. In fact, neutralization of IL-10 by an anti-IL-10 antibody significantly 
increased the IL-6 production in PGN stimulated DCs both in presence or absence of NE (Fig. 
22). This demonstrated that the augmented IL-10 production in PGN+NE stimulated DCs was 
indeed responsible for the decreased IL-6 concentration in DCs culture supernatant. 
Moreover, neutralization of IL-10 in DCs incubated with PAM in presence or absence of NE 
had no significant effect on IL-6 (Fig. 23), further demonstrating that IL-10 may inhibit IL-6 
production triggered by NOD2 but not by TLR-2 signaling. In contrast with PGN, NE had no 
significant effect on the PAM+MDP induced IL-6 production. Nevertheless, addition of the 
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IL-10 neutralizing antibody significantly increased IL-6 in PAM+MDP stimulated DCs in 
presence but not in absence of NE (Fig. 24). This seemingly contrasting results might be due 
to the concentration of IL-10 needed for an effective inhibition of IL-6. In fact, the IL-10 
concentration in PGN stimulated DCs was three times higher than in PAM+MDP treated 
DCs. In addition, the PAM/MDP ratio used in our experiments was possibly different from 
the ratio between TLR-2 and NOD2 agonists in PGN and such a difference was probably in 
favor of NOD2. In fact, NE did not influence IL-6 production in PAM+MDP treated DCs 
even if the concentration of IL-10 was slightly increased, probably because of the high 
proportion of MDP compared to PAM. 
In regard to the IL-6 gene expression in PGN, PAM and PAM+MDP treated DCs, we found 
that addition of NE to the culture medium had no significant effect on the IL-6 mRNA 
expression. This suggested that IL-10 may exerts its inhibitory effect on PGN treated DCs at a 
post-transcriptional level. Nevertheless, it is known that IL-10 exerts its anti-inflammatory 
effects indirectly primarily by inhibition of proinflammatory gene transcription. IL-10 
activates the transcription factor STAT3, which may then activate the expression of other 
anti-inflammatory genes which subsequently may inhibit the proinflammatory genes64. 
Perhaps, in our case this anti-inflammatory genes might exerts their immunosuppressive 
action by inhibiting the IL-6 production at a post-transcriptional level. 
Finally, we demonstrated that NE inhibits IL-23 in DCs incubated with PGN. PAM or MDP 
stimulated DCs did not produce substantial amounts of IL-23 either in presence or absence of 
NE. However, when DCs were incubated with PAM+MDP, an appreciably production of this 
cytokine was found, suggesting that, as for IL-12, PAM and MDP may act synergistically to 
induce IL-23 production (Fig. 20). Interestingly, addition of NE in DCs incubated with 
PAM+MDP had no significant effect on IL-23 production. Again, the difference between 
PGN and PAM+MDP treated cells might be due to the ability of PGN to bind to receptors 
other than TLR-2 and NOD2 and to the different proportion of TLR-2 and NOD2 agonists in 
PGN. 
As for IL-6, we wondered if the decreased production of IL-23 might be due to the anti-
inflammatory properties of IL-10. Neutralization of IL-10 in PGN+NE, PAM+NE and 
PAM+MDP+NE treated cells, significantly augmented IL-23 production suggesting that, in 
contrast with IL-6, IL-23 induced from TLR-2 activation might be inhibited by IL-10. Again, 
as demonstrated by the analysis of the mRNA expression and as hypothesized for IL-6, the 
inhibition of IL-23 by IL-10 might take place at a post-transcriptional level. 
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In conclusion, these results provided evidence of a discrete noradrenergic modulation via β-
ARs of the cytokines production in DCs stimulated with different PRRs. Hence, we wondered 
if such a modulation could also influence Th development and differentiation during an 
immune response to a soluble protein. Our preliminary results clearly indicated that addition 
of the β2-ARs agonist salbutamol to DCs stimulated in vitro with PAM+MDP and loaded 
with KLH before injection, inhibited IFN-γ and, to a much lesser extent, IL-17 production in 
draining lymph node cells restimulated in vitro with the soluble protein (Fig. 31). 
Interestingly, although the IL-17 production was not increased, the ratio of IFN-γ over IL-17 
switched in favor of IL-17. These results suggested that β2-ARs activation in DCs may 
selectively inhibit Th1 cell differentiation while sparing the TLR-2 and NOD2 induced Th17 
cell polarization. 
Thus, it is possible that in case of stimulating DCs with PGN instead of PAM+MDP, addition 
of β2-AR agonists might induce Th17 cell differentiation. Accordingly, our in vitro results 
showed that addition of NE to DCs stimulated with PGN reduced by 90% the IL-12 
production, known to be essential for Th1 primig, while IL-6 and IL-23, which are involved 
in Th17 differentiation, were just reduced by 27% and 39% respectively. This modification of 
the cytokine pattern suggested that, as for PAM+MDP treated cells, in PGN stimulated DCs, 
β2-ARs may influence the balance between Th1 and Th17 cell differentiation in favor of 
Th17. 
These results are in agreement also with our in vivo studies. In fact, preconditioning of mice 
skin with PGN+PRO significantly increased the gene expression of IFN-γ and of others 
proinflammatory cytokines. Moreover, the IFN-γ production in the draining lymph nodes 
assessed after mice skin preconditioning with PGN+PRO followed by injection of a soluble 
protein was also increased, while no effect on the IL-4 production was observed. IFN-γ, 
which is a Th1 cytokine, is known to exert an inhibitory effect on Th17 cell development. 
Thus, these results suggested that in vivo the Th1 polarization induced by β-ARs blockade 
was not at the expense of Th2 priming but rather at that of Th17 polarization. 
When we tested in vitro the effect of the addition of NE on cytokines production in DCs 
incubated with LPS, we observed that the proinflammatory cytokines IL-12, IL-6 and IL-23 
were decreased while the anti-inflammatory cytokine IL-10 was increased. These results were 
in contrast with our in vivo results, where the pharmacological blocking of the β-ARs along 
with TLR-4 activation by LPS had no effect on the cytokine gene expression in mice skin. 
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The different cytokines modulation in the in vivo and in vitro experiments may be due to the 
presence in the skin of many different cells types, which may react to β-ARs inhibition in a 
different way than DCs. For instance, TLR-4 and β-ARs may be expressed in mice skin on 
DCs but also on macrophages, mast cells, fibroblasts and endothelial cells. The different 
contribution of each cell subpopulation to the inflammatory response may thus account for the 
diverse results obtained in vitro and in vivo. 
We observed also that LPS induced a greater production of IL-12 and IL-23 than PGN and 
that addition of NE to LPS treated DCs had a stronger effect on IL-6 and IL-23 production, 
reduced respectively by 45% and 53%, than in PGN treated DCs. This difference is probably 
due to the ability of PGN to bind to PRRs different from TLR-2, in particular to the NOD2 
receptor. We demonstrated that activation of the NOD2 receptor in presence of NE increased 
IL-6 production. This might explain the minor reduction of IL-6 in PGN treated cells 
compared to LPS treated cells in presence of NE. 
However, these results do not explain the different adrenergic modulation of PGN and LPS in 
vivo but suggests the existence of a possible difference in the β-ARs modulation. Maybe, in 
LPS treated cells β-ARs activation may decrease not only Th1 cell differentiation by 
inhibiting IL-12 but, in contrast to PGN, also the Th17 cell development by inhibiting IL-6 
and IL-23. Further experiments are needed to verify this working hypothesis of Th 
differentiation ensuing upon PGN versus LPS injection. 
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VII. Conclusion 
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In conclusion, we supported our previous findings obtained in vivo (Results part I) by 
demonstrating that in DCs NE may differently modulate pro- and anti-inflammatory cytokines 
production according to the type of PRRs activation. In particular, we confirmed the 
inhibitory ability of NE on IL-12 production and we demonstrated that activation of the 
NOD2 receptor in presence of NE leads to an augmented production of IL-6. In contrast, 
activation of TLR-2 in presence of NE resulted in an increased production of the anti-
inflammatory cytokine IL-10. Moreover, we demonstrated that the TLR-2 induced IL-10 
might inhibit IL-6 and IL-23 production by exerting indirectly its action possibly at the post-
transcriptional level. 
IL-6 is a pleiotropic cytokine involved in many different mechanisms, notably in the 
inflammatory response, hematopoiesis and T cells differentiation. However, IL-6 has also 
been reported to be involved in many different diseases such as chronic inflammatory bowel 
diseases and rheumatoid arthritis. In Crohn’s disease and in ulcerative colitis, which are 
inflammatory bowel diseases, IL-6 may activate the transcription factor STAT-3 in T cells by 
binding the soluble IL-6 receptor. Then, STAT-3 may induce some anti-apoptotic factors 
resulting in T cell resistance to apoptosis. T cells may then accumulate in tissues and cause  
chronic inflammation14. In murine models of rheumatoid arthritis, IL-6 knock out mice failed 
to develop joint swelling and lesions characteristic of this disease15. Moreover high levels of 
IL-6 in serum were correlated with high arthritis indexes. 
Thus, a deregulation of the mechanisms controlling IL-6 production may leads to an increased 
IL-6 concentration and signaling and to the development of related pathologies. Our findings 
may be relevant in understanding the mechanisms regulating IL-6 production in PRRs 
activated DCs and, in particular, they demonstrate the involvement of β-ARs. Consequently, 
these results may be helpful in our understanding of the pathogenesis of many diseases. In 
addition, IL-6, together with IL-23, has been implicated in the development of the newly 
discovered Th17 cell lineage. Most interesting, it has been reported that stimulation of the 
NOD2 receptor induced the production of IL-17 in human memory T cells65. Consistently, we 
found that activation of NOD2 receptor leads to IL-6 production, which may be increased by 
NE. Moreover, our preliminary results demonstrated that adoptive transfer of DCs stimulated 
in vitro in presence of the β2-AR agonist salbutamol influenced the Th differentiation by 
inhibiting the Th1 development in favor of Th17 cells. In addition, mice skin preconditioning 
with PGN+PRO followed by injection of a soluble protein increased the IFN-γ production in 
the draining lymph nodes probably affecting the balance between Th1 and Th17. 
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The Th17 cell lineage is known to be necessary in the immune response against extracellular 
bacteria and parasitic worms. Nevertheless, high levels of IL-17 production have been 
associated with the development of cancer and autoimmune and inflammatory diseases. For 
instance IL-17 is produced in rheumatoid arthritis synovium66, psoriasis67 and in mouse 
experimental autoimmune encephalomyelitis (EAE)29 and collagen induced arthritis (CIA). 
Absence of IL-6, which is needed for Th17 priming, protected mice against both EAE and 
CIA68,69. It has also been reported that IL-23 and IL-17 are increased in human tumors and 
that IL-23 deficient mice develop a tumor resistance associated with a decreased 
inflammation to cutaneous chemical carcinogenesis70. 
Our in vivo and in vitro findings provide evidence of a β-ARs implication in modulating the 
Th lineage development by modulating the cytokines production upon different PRRs 
activation. Consequently, β-ARs might also be implicated in the development of cancer, 
autoimmune and inflammatory disease by promoting Th17 polarization. A deregulation of the 
adrenergic system might result in a deregulated response to bacteria involving an 
inappropriate Th development causing an increased risk for autoimmune or inflammatory 
diseases. In addition, our findings might provide new perspectives in the therapeutic 
utilization of β2-AR agonists and in the interpretation of their clinical efficacy. In conclusion, 
a complete understanding of the β-ARs influence on the Th differentiation might have a far 
reaching pathophysiological relevance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 102 
 
 
 
 
 
 
 
 
 
 
 
VIII. Bibliography 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 103 
                                                                                                                                                   
1 Mak, T.W., Saunders, M.E., 2006. The immune response, basic and clinical principles. 
Elsevier Academic Press. 
 
2 Pivarcsi, A., Nagy, I., Kemeney, L., 2005. Innate immunity in the skin: How keratinocytes 
fight against pathogens. Curr. Immunol. Review 1, 29-42. 
 
3 Kawai, K., Shimura, H., Minagawa, M., Ito, A., Tomiyama, K., Ito, M., 2002. Expression of 
functional Toll-like receptor 2 on human epidermal keratinocytes. J. Dermatol. Sci. 30, 185-
194. 
 
4 Pivarcsi, A., Bodai, L., Réthi, B., Kenderessy-Szabó, A., Koreck, A., Széll, M., Beer, Z., 
Bata-Csörgoo, Z., Magócsi, M., Rajnavölgyi, E., Dobozy, A., Kemény, L., 2003. Expression 
and function of Toll-like receptors 2 and 4 in human keratinocytes. Int. Immunol. 15, 721-
730. 
 
5 Roosterman, D., Goerge, T., Schneider, S.W., Bunnett, N.W., Steinhoff, M., 2006. Neuronal 
control of skin function: the skin as a neuroimmunoendocrine organ. Physiol. Rev. 86, 1309-
1379. 
 
6 Haniffa, M.A., Wang, X.N., Holtick, U., Rae, M., Isaacs, J.D., Dickinson, A.M., Hilkens, 
C.M., Collin, M.P., 2007. Adult human fibroblasts are potent immunoregulatory cells and 
functionally equivalent to mesenchymal stem cells. J. Immunol. 179, 1595-1604. 
 
7 Gordon, J.R., Galli, S.J., 1990. Mast cells as a source of both preformed and 
immunologically inducible TNF-α / cachectin. Nature 346, 274-276. 
 
8 Akira, S., Uematsu, S., Takeuchi, O., 2006, Pathogen Recognition and Innate Immunity, 
Cell 124, 783-801. 
 
9 Meylan, E., Burns, K., Hofmann, K., Blancheteau, V., Martinon, F., Kelliher, M., Tschopp, 
J., 2004. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. 
Nat. Immunol. 5, 503-507. 
Michela Manni Institut de Biologie Université de Neuchâtel 
 104 
                                                                                                                                                   
10 Fitzgerald, K.A., Rowe, D.C., Barnes, B.J., Caffrey, D.R., Visintin, A., Latz, E., Monks, B., 
Pitha, P.M., Golenbock, D.T., 2003. LPS-TLR4 signaling to IRF-3/7 and NF-kappa B 
involves the toll adapters TRAM and TRIF. J. Exp. Med. 198, 1043-1055. 
 
11 Le Bourhis, L., Benko, S., Girardin, S.E., 2007. Nod1 and Nod2 in innate immunity and 
human inflammatory disorders. Biochem Soc Trans. 35, 1479-1484. 
 
12 Strober, W., Murray, P.J., Kitani, A., Watanabe, T., 2006. Signalling pathway and 
molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6, 9-20. 
 
13 Paludan, S.R., 1998. Interleukin-4 and interferon-gamma: the quintessence of a mutual 
antagonistic relationship. Scand. J. Immunol. 48, 459-468. 
 
14 Mudter, J., Neurath, M.F., 2007. IL-6 signaling in inflammatory bowel disease: 
pathophysiological role and clinical relevance. Inflamm. Bowel Dis. 13, 1016-1023. 
 
15 Park, J.Y., Pillinger, M.H., 2007. Interleukin-6 in the pathogenesis of rheumatoid arthritis. 
Bull. NYU Hosp. Jt. Dis. 65, 4-10. 
 
16 Peluso, I., Pallone, F., Monteleone, G., 2006. Interleukin-12 and Th1 immune response in 
Crohn's disease: pathogenetic relevance and therapeutic implication. World J. Gastroenterol. 
12, 5606-5610. 
 
17 Segal, B.M., Dwyer, B.K., Shevach, E.M., 1998. An interleukin (IL)-10/IL-12 
immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187, 
537-546. 
 
18 Dong, C., 2006. Diversification of T-helper-cell lineages: finding the family root of IL-17-
producing cells. Nat. Rev. Immunol. 6, 329-333. 
 
19 Chabaud, M., Durand, J.M., Buchs, N., Fossiez, F., Page, G., Frappart, L., Miossec, P., 
1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the 
rheumatoid synovium. Arthritis Rheum. 42, 963-970. 
Michela Manni Institut de Biologie Université de Neuchâtel 
 105 
                                                                                                                                                   
20 Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Ozenci, V., Fredrikson, S., Link, H., 
1999. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in 
multiple sclerosis. Mult. Scler. 5, 101-104. 
 
21 Piskin, G., Sylva-Steenland, R.M., Bos, J.D., Teunissen, M.B., 2006. In vitro and in situ 
expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced 
expression in psoriatic skin. J. Immunol. 176, 1908-1915. 
 
22 Chen, Z., O'Shea, J.J., 2008. Th17 cells: a new fate for differentiating helper T cells. 
Immunol. Res. In press. 
 
23 Letterio, J.J., Roberts, A.B., 1998. Regulation of immune responses by TGF-beta. Annu. 
Rev. Immunol. 16, 137-161. 
 
24 Tato, C.M., O’Shea, J.J., 2006. What does it mean to be just 17? Nature 441, 166-168. 
 
25 Moser, M., Murphy, K.M., 2000. Dendritic cell regulation of TH1-TH2 development. Nat. 
Immunol. 1, 199-205. 
 
26 Rao, A., Avni, O., 2000. Molecular aspects of T-cell differentiation. Br. Med. Bull. 56, 969-
984. 
 
27 Ghoreschi, K., Weigert, C., Röcken, M., 2007. Immunopathogenesis and role of T cells in 
psoriasis. Clin. Dermatol. 25, 574-580. 
 
28 Averbeck, M., Gebhardt, C., Emmrich, F., Treudler, R., Simon, J.C., 2007. Immunologic 
principles of allergic disease. J. Dtsch. Dermatol. Ges. 5, 1015-1028. 
 
29 Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., 
Kuchroo, V., 2006. Reciprocal developmental pathway for the generation of pathogenic 
effector Th17 and regulatory T cells. Nature 441, 235-238. 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 106 
                                                                                                                                                   
30 Mangan, P.R., Harrington, L.E., O’Quinn, D.B., Helms, W.S., Bullard, D.C., Elson, C.O., 
Hatton, R.D., Wahl, S.M., Schoeb, T.R., Weaver, C.T., 2006. Transforming growth factor-β 
induces development of the Th17 lineage. Nature 441, 231-234. 
 
31 Yang, X.O., Panopoulos, A.D., Nurieva, R., Chang, S.H., Wang, D., Watowich, S.S., Dong, 
C., 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. 
Biol. Chem. 282, 9358-9363. 
 
32 Paradowska, A., Maślińiski, W., Grzybowska-Kowalczyk, A., Łacki, J., 2007. The function 
of interleukin 17 in the pathogenesis of rheumatoid arthritis. Arch. Immuno. Ter. Exp. 55, 
329-334. 
 
33 O'Garra, A., Vieira, P., 2004. Regulatory T cells and mechanisms of immune system 
control. Nat. Med. 10, 801-805. 
 
34 Hadden, J.W., Hadden, E.M., Middleton, E. Jr., 1970. Lymphocyte blast transformation. I. 
Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol. 1, 
583-595. 
 
35 Besedovsky, H., del Rey, A., Sorkin, E., Dinarello, C.A., 1986. Immunoregulatory 
feedback between interleukin-1 and glucocorticoid hormones. Science 233, 652-654. 
 
36 Ader, R., Cohen, N., 1982. Behaviorally conditioned immunosuppression and murine 
systemic lupus erythematosus. Science 215, 1534-1536. 
 
37 Keller, S.E., Weiss, J.M., Schleifer, S.J., Miller, N.E., Stein, M., 1983. Stress-induced 
suppression of immunity in adrenalectomized rats. Science 221, 1301–1304. 
 
38 Cohen, S., Tyrrell, D.A., Smith, A.P., 1991. Psychological stress and susceptibility to the 
common cold. N. Engl. J. Med. 325, 606–612. 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 107 
                                                                                                                                                   
39 Purves, D., Augustine, G.J., Fitzpatrick, D., Katz, L.C., LaMantia, A.S., McNamara, J.O., 
1999. Neurosciences. DeBoeck Université. 
 
40 Elenkov, I.J., Wilder, R.L., Chrousos, G.P., Vizi, E.S., 2000. The sympathetic nerve-an 
integrative interface between two supersystems: the brain and the immune system. 
Pharmacol. Rev. 52, 595-638. 
 
41 Sanders, V.M., Baker, R.A., Ramer-Quinn, D.S., Kasprowicz, D.J., Fuchs, B.A., Street, 
N.E., 1997. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: 
implications for cytokine production and B cell help. J. Immunol. 158, 4200-4210. 
 
42 Nance, D.M., Sanders, V.M., 2007. Autonomic innervation and regulation of the immune 
system (1987-2007). Brain Behav. Immun. 21, 736-745. 
 
43 Hasko, G., Szabo, C., Nemeth, Z.H., Salzman, A.L., Vizi, E., 1998. Stimulation of beta-
adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient 
mice. J. Neuroimmunol. 88, 57-61. 
 
44 Panina-Bordignon, P., Mazzeo, D., Lucia, P.D., D'Ambrosio, D., Lang, R., Fabbri, L., Self, 
C., Sinigaglia, F., 1997. Beta2-agonists prevent Th1 development by selective inhibition of 
interleukin 12. J. Clin. Invest. 100, 1513-1519. 
 
45 Van der Poll, T., Lowry, S.F., 1997. Epinephrine inhibits endotoxin-induced IL-1 beta 
production: roles of tumor necrosis factor-alpha and IL-10. Am. J. Physiol. 273, 1885-1890. 
 
46 Tan, K.S., Nackley, A.G., Satterfield, K., Maixner, W., Diatchenko, L., Flood, P.M., 2007. 
Beta2 adrenergic receptor activation stimulates proinflammatory cytokine production in 
macrophages via PKA- and NF-kappaB-independent mechanisms. Cell Signal. 19, 251-260. 
 
47 Varas, A., Jiménez, E., Muñoz, J.J., Zapata, A.G., 1999. Glucocorticoid-mediated 
regulation of thymic dendritic cell function. Int. Immunol. 11, 1217-1224. 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 108 
                                                                                                                                                   
48 Ma, W., Gee, K., Lim, W., Chambers, K., Angel, J.B., Kozlowski, M., Kumar, A., 2004. 
Dexamethasone inhibits IL-12p40 production in lipopolysaccharide-stimulated human 
monocytic cells by down-regulating the activity of c-Jun N-terminal kinase, the activation 
protein-1, and NF-kappa B transcription factors. J. Immunol. 172, 318-330. 
 
49 Viveros-Paredes, J.M., Puebla-Pérez, A.M., Gutiérrez-Coronado, O., Sandoval-Ramírez, 
L., Villaseñor-García, M.M., 2006. Dysregulation of the Th1/Th2 cytokine profile is 
associated with immunosuppression induced by hypothalamic-pituitary-adrenal axis 
activation in mice. Int. Immunopharmacol. 6, 774-781. 
 
50 Miyamasu, M., Misaki, Y., Izumi, S., Takaishi, T., Morita, Y., Nakamura, H., Matsushima, 
K., Kasahara, T., Hirai, K., 1998. Glucocorticoids inhibit chemokine generation by human 
eosinophiles. J. Allergy Clin. Immunol. 101, 75-83. 
 
51 Maestroni, G.J., 2000. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. 
J. Immunol. 165, 6743-6747. 
 
52 Maestroni, G.J., 2002. Short exposure of maturing, bone marrow-derived dendritic cells to 
norepinephrine: impact on kinetics of cytokine production and Th development. J. 
Neuroimmunol. 129, 106-114. 
 
53 Seiffert, K., Hosoi, J., Torii, H., Ozawa, H., Ding, W., Campton, K., Wagner, J.A., 
Granstein, R.D., 2002. Catecholamines inhibit the antigen-presenting capability of epidermal 
Langerhans cells. J. Immunol. 168, 6128-6135. 
 
54 Maestroni, G.J., Mazzola, P., 2003. Langerhans cells beta 2-adrenoceptors: role in 
migration, cytokine production, Th priming and contact hypersensitivity. J. Neuroimmunol. 
144, 91-99. 
 
55 Botta, F., Maestroni, G.J.M., 2008. Adrenergic modulation of dendritic cell cancer vaccine 
in a mouse model, role of dendritic cell maturation. J. Immunother. In press. 
 
Michela Manni Institut de Biologie Université de Neuchâtel 
 109 
                                                                                                                                                   
56 Matsutani, T., Tanaka, T., Tohya, K., Otani, K., Jang, M.H., Umemoto, E., Taniguchi, K., 
Hayasaka, H., Ueda, K., Miyasaka, M., 2007. Plasmacytoid dendritic cells employ multiple 
cell adhesion molecules sequentially to interact with high endothelial venule cells - molecular 
basis of their trafficking to lymph nodes. Int. Immunol. 19, 1031-1037. 
 
57 Asselin-Paturel, C., Brizard, G., Chemin, K., Boonstra, A., O'Garra, A., Vicari, A., 
Trinchieri, G., 2005. Type I interferon dependence of plasmacytoid dendritic cell activation 
and migration. J. Exp. Med. 201, 1157-1167. 
 
58 Kohrgruber, N., Gröger, M., Meraner, P., Kriehuber, E., Petzelbauer, P., Brandt, S., Stingl, 
G., Rot, A., Maurer, D., 2004. Plasmacytoid dendritic cell recruitment by immobilized 
CXCR3 ligands. J. Immunol. 173, 6592-6602. 
 
59 Dziarski, R., Gupta, D., 2005. Peptidoglycan recognition in innate immunity. J. Endotoxin 
Res. 11, 304-310. 
 
60 Takeshita, S., Gage, J.R., Kishimoto, T., Vredevoe, D.L., Martinez-Maza, O., 1996. 
Differential regulation of IL-6 gene transcription and expression by IL- 4 and IL-10 in human 
monocytic cell lines. J. Immunol. 156, 2591-2598. 
 
61 Marshall, J.S., Leal-Berumen, I., Nielsen, L., Glibetic, M., Jordana, M., 1996. Interleukin 
(IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat 
peritoneal mast cells. J. Clin. Invest. 97, 1122-1128. 
 
62 Heyen, J.R., Ye, S., Finck, B.N., Johnson, R.W., 2000. Interleukin (IL)-10 inhibits IL-6 
production in microglia by preventing activation of NF-κB. Brain Res. Mol. Brain Res. 77, 
138-147. 
 
63 Palframan, R.T., Jung, S., Cheng, G., Weninger, W., Luo, Y., Dorf, M., Littman, D.R., 
Rollins, B.J., Zweerink, H., Rot, A., von Andrian, U.H., 2001. Inflammatory chemokines 
transport and presentation in HEV: a remote control mechanism for monocytes recruitment to 
lymph nodes in inflamed tissues. J. Exp. Med. 194, 1361-1373. 
Michela Manni Institut de Biologie Université de Neuchâtel 
 110 
                                                                                                                                                   
64 El Kasmi, K.C., Holst, J., Coffre, M., Mielke, L., de Pauw, A., Lhocine, N., Smith, A.M., 
Rutscman, R., Kaushal, D., Shen, Y., Suda, T., Donnely, R.P., Myers, M.G.Jr., Alexander, 
W., Vignali, D.A.A., Watowich, S.S., Ernst, M., Hilton, D.J., Murray, P.J., 2006. General 
nature of the STAT3-activated anti inflammatory response. J. Immunol. 177, 7880-7888. 
 
65 Van Beelen, A.J., Zelinkova, Z., Taanman-Kueter, E.W., Muller, F.J., Hommes, D.W., 
Zaat, S.A., Kapsenberg, M.L., de Jong, E.C., 2007. Stimulation of the intracellular bacterial 
sensor NOD2 programs dendritic cells to promote interleukin-17 production in human 
memory T cells. Immunity. 27, 660-669. 
 
66 Chabaud, M., Durand, J.M., Buchs, N., Fossiez, F., Page, G., Frappart, L., Miossec, P., 
1999. Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the 
rheumatoid synovium. Arthritis Rheum. 42, 963-970. 
 
67 Fitch, E., Harper, E., Skorcheva, I., Kurtz, S.E., Blauvelt, A., 2007. Pathophysiology of 
psoriasis: recent advances on IL-23 and Th17 cytokines. Curr. Rheumatol. Rep. 9, 461-467. 
 
68 Okuda, Y., Sakoda, S., Bernard, C.C., Fujimura, H., Saeki, Y., Kishimoto, T., Yanagihara, 
T., 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune 
encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int. Immunol. 10, 703-
708. 
 
69 Aloni, T., Fattori, E., Lazzaro, D., Costa, P., Probert, L., Kollias, G., De Benedetti, F., Poli, 
V., Ciliberto, G., 1998. Interleukin 6 is required for the development of collagen-induced 
arthritis. J. Exp. Med. 187, 461-468. 
 
70 Langowski, J.L., Zhang, X., Wu, L., Mattson, J.D., Chen, T., Smith, K., Basham, B., 
McClanahan, T., Kastelein, R.A., Oft, M., 2006. IL-23 promotes tumour incidence and 
growth. Nature 442, 461-465. 
 
